Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-106a-5p AKT3 -0.2 0.80221 0.46 0.53933 miRNATAP -0.55 0 NA
2 hsa-miR-106b-5p AKT3 -0.3 0.86929 0.46 0.53933 miRNATAP -0.91 0 NA
3 hsa-miR-107 AKT3 -0.04 0.98836 0.46 0.53933 PITA; miRanda -0.55 0.00017 NA
4 hsa-miR-1275 AKT3 -0.83 0.08038 0.46 0.53933 PITA -0.27 0 NA
5 hsa-miR-142-3p AKT3 -0.15 0.9461 0.46 0.53933 miRanda -0.2 0.00627 NA
6 hsa-miR-15a-5p AKT3 -0.07 0.96484 0.46 0.53933 miRNAWalker2 validate; miRTarBase; miRNATAP -0.72 0 NA
7 hsa-miR-15b-5p AKT3 -0.27 0.87097 0.46 0.53933 miRNATAP -0.67 0 NA
8 hsa-miR-16-5p AKT3 0.01 0.99448 0.46 0.53933 miRNAWalker2 validate; miRTarBase; miRNATAP -0.75 0 NA
9 hsa-miR-17-3p AKT3 0.1 0.96011 0.46 0.53933 miRNATAP -0.52 0 NA
10 hsa-miR-17-5p AKT3 -0.18 0.93454 0.46 0.53933 TargetScan; miRNATAP -0.63 0 NA
11 hsa-miR-181b-5p AKT3 0.16 0.93018 0.46 0.53933 miRNATAP -0.27 0.00963 NA
12 hsa-miR-20a-5p AKT3 -0.18 0.92812 0.46 0.53933 miRNATAP -0.53 0 NA
13 hsa-miR-28-3p AKT3 -0.23 0.93535 0.46 0.53933 miRNATAP -0.52 0.00719 NA
14 hsa-miR-29a-3p AKT3 0.01 0.99698 0.46 0.53933 miRNATAP -0.81 0 NA
15 hsa-miR-29b-3p AKT3 -0.1 0.95899 0.46 0.53933 miRNATAP -0.68 0 26512921 MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3
16 hsa-miR-32-3p AKT3 -0.57 0.13133 0.46 0.53933 mirMAP -0.56 0 NA
17 hsa-miR-320a AKT3 -0.42 0.8402 0.46 0.53933 PITA; miRanda; miRNATAP -0.33 0.00138 NA
18 hsa-miR-320b AKT3 -0.24 0.85922 0.46 0.53933 PITA; miRanda; miRNATAP -0.25 0.00855 NA
19 hsa-miR-335-3p AKT3 -0.24 0.8845 0.46 0.53933 mirMAP -0.58 0 NA
20 hsa-miR-33a-3p AKT3 -0.79 0.01052 0.46 0.53933 mirMAP -0.49 0 NA
21 hsa-miR-340-5p AKT3 -0 0.99757 0.46 0.53933 mirMAP -0.28 0.006 NA
22 hsa-miR-362-3p AKT3 -0.72 0.03459 0.46 0.53933 miRanda -0.42 0 NA
23 hsa-miR-362-5p AKT3 -0.27 0.75202 0.46 0.53933 PITA; TargetScan; miRNATAP -0.52 0 NA
24 hsa-miR-369-3p AKT3 0.12 0.8323 0.46 0.53933 mirMAP -0.23 0.00901 NA
25 hsa-miR-374a-5p AKT3 -0.34 0.76692 0.46 0.53933 mirMAP -0.58 0 NA
26 hsa-miR-374b-5p AKT3 -0.29 0.8357 0.46 0.53933 mirMAP -0.68 0 NA
27 hsa-miR-421 AKT3 -0.18 0.7347 0.46 0.53933 miRanda; mirMAP -0.46 0 NA
28 hsa-miR-424-5p AKT3 0.25 0.87015 0.46 0.53933 miRNATAP -0.24 0.00104 26315541 Silencing Akt3 and E2F3 by siRNA pheno-copied the effect of ectopic miR-424 on HCC growth; Whereas overexpression of Akt3 and E2F3 attenuated the effect of miR-424 on HCC growth
29 hsa-miR-501-3p AKT3 -0.75 0.55276 0.46 0.53933 miRNATAP -0.5 0 NA
30 hsa-miR-502-3p AKT3 -0.48 0.5143 0.46 0.53933 miRNATAP -0.64 0 NA
31 hsa-miR-502-5p AKT3 -0.71 0.02613 0.46 0.53933 PITA; miRNATAP -0.41 0 NA
32 hsa-miR-505-3p AKT3 -0.47 0.69038 0.46 0.53933 mirMAP -0.77 0 22051041 We also find that Akt3 correlate inversely with miR-505 modulates drug sensitivity in MCF7-ADR
33 hsa-miR-548o-3p AKT3 -0.19 0.51773 0.46 0.53933 mirMAP -0.31 8.0E-5 NA
34 hsa-miR-577 AKT3 -1.06 0.32606 0.46 0.53933 mirMAP -0.38 0 NA
35 hsa-miR-663b AKT3 0.1 0.81499 0.46 0.53933 PITA -0.25 1.0E-5 NA
36 hsa-miR-769-5p AKT3 -0.31 0.7357 0.46 0.53933 PITA; miRNATAP -0.84 0 NA
37 hsa-miR-93-5p AKT3 -0.61 0.8253 0.46 0.53933 miRNATAP -0.76 0 NA
38 hsa-miR-335-5p ARRB1 -0.03 0.97338 -0.32 0.77157 miRNAWalker2 validate -0.12 0.00397 NA
39 hsa-let-7a-3p ATF2 -0.22 0.85543 -0.2 0.8347 MirTarget; mirMAP; miRNATAP -0.15 4.0E-5 NA
40 hsa-miR-126-5p ATF2 0.08 0.95664 -0.2 0.8347 mirMAP -0.18 1.0E-5 NA
41 hsa-miR-154-3p ATF2 -0.17 0.5465 -0.2 0.8347 MirTarget; miRNATAP -0.11 0.00067 NA
42 hsa-miR-15a-5p ATF2 -0.07 0.96484 -0.2 0.8347 miRNAWalker2 validate -0.12 0.00218 NA
43 hsa-miR-221-3p ATF2 0.09 0.95912 -0.2 0.8347 MirTarget -0.15 0.00024 NA
44 hsa-miR-222-3p ATF2 -0.03 0.98401 -0.2 0.8347 MirTarget -0.15 3.0E-5 NA
45 hsa-miR-26a-5p ATF2 0.01 0.99772 -0.2 0.8347 MirTarget; miRNATAP -0.2 0.00157 NA
46 hsa-miR-26b-5p ATF2 -0.02 0.99038 -0.2 0.8347 MirTarget; miRNATAP -0.18 2.0E-5 21901137 Coordinated regulation of ATF2 by miR 26b in γ irradiated lung cancer cells; Concurrent analysis of time-series mRNA and microRNA profiles uncovered that expression of miR-26b was down regulated and its target activating transcription factor 2 ATF2 mRNA was up regulated in γ-irradiated H1299 cells; IR in miR-26b overexpressed H1299 cells could not induce expression of ATF2; From these results we concluded that IR-induced up-regulation of ATF2 was coordinately enhanced by suppression of miR-26b in lung cancer cells which may enhance the effect of IR in the MAPK signaling pathway
47 hsa-miR-29a-5p ATF2 -0.32 0.60044 -0.2 0.8347 MirTarget; miRNATAP -0.12 4.0E-5 NA
48 hsa-miR-30b-5p ATF2 -0.01 0.99462 -0.2 0.8347 mirMAP -0.16 0 NA
49 hsa-miR-30c-5p ATF2 -0.3 0.86581 -0.2 0.8347 mirMAP -0.2 1.0E-5 NA
50 hsa-miR-32-3p ATF2 -0.57 0.13133 -0.2 0.8347 miRNATAP -0.11 0 NA
51 hsa-miR-369-3p ATF2 0.12 0.8323 -0.2 0.8347 MirTarget; PITA; miRNATAP -0.19 0 NA
52 hsa-miR-374b-5p ATF2 -0.29 0.8357 -0.2 0.8347 miRNAWalker2 validate; mirMAP; miRNATAP -0.15 0.0006 NA
53 hsa-let-7a-3p BDNF -0.22 0.85543 0.5 0.16933 MirTarget; miRNATAP -0.24 0.00935 NA
54 hsa-miR-15a-5p BDNF -0.07 0.96484 0.5 0.16933 MirTarget; miRNATAP -0.36 0.00046 26581909 MicroRNA 15a 5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF; BDNF was then overexpressed in HepG2 and SNU-182 cells to evaluate its selective effect on miR-15a-5p in HCC modulation; MiR-15a-5p selectively and negatively regulated BDNF at both gene and protein levels in HCC cells; Forced overexpression of BDNF effectively reversed the tumor suppressive functions of miR-15a-5p on HCC proliferation and cell division in vitro; Our study demonstrated that miR-15a-5p is a tumor suppressor in HCC and its regulation is through BDNF in HCC
55 hsa-miR-15b-5p BDNF -0.27 0.87097 0.5 0.16933 MirTarget; miRNATAP -0.32 0.00075 NA
56 hsa-miR-16-5p BDNF 0.01 0.99448 0.5 0.16933 MirTarget; miRNATAP -0.34 0.00032 NA
57 hsa-miR-191-5p BDNF -0.48 0.81535 0.5 0.16933 miRNATAP -0.33 0.00023 NA
58 hsa-miR-210-3p BDNF -0.53 0.78221 0.5 0.16933 miRNAWalker2 validate; miRTarBase -0.18 0.0001 NA
59 hsa-miR-26b-3p BDNF -0.36 0.68112 0.5 0.16933 MirTarget -0.27 0.00219 NA
60 hsa-miR-29b-1-5p BDNF -0.64 0.29389 0.5 0.16933 mirMAP -0.21 0.00039 NA
61 hsa-miR-30b-5p BDNF -0.01 0.99462 0.5 0.16933 miRNATAP -0.26 0.00173 NA
62 hsa-miR-32-3p BDNF -0.57 0.13133 0.5 0.16933 miRNATAP -0.29 0 NA
63 hsa-miR-339-5p BDNF -0.3 0.71291 0.5 0.16933 miRanda -0.26 0.00013 NA
64 hsa-miR-33a-3p BDNF -0.79 0.01052 0.5 0.16933 mirMAP -0.19 0.00849 NA
65 hsa-miR-452-3p BDNF -0.17 0.79901 0.5 0.16933 MirTarget -0.17 0.00525 NA
66 hsa-miR-577 BDNF -1.06 0.32606 0.5 0.16933 mirMAP; miRNATAP -0.18 4.0E-5 NA
67 hsa-miR-589-3p BDNF -0.84 0.0112 0.5 0.16933 MirTarget -0.29 1.0E-5 NA
68 hsa-miR-589-5p BDNF -0.45 0.72273 0.5 0.16933 miRNATAP -0.38 0.00124 NA
69 hsa-miR-590-3p BDNF -0.28 0.59127 0.5 0.16933 miRanda; mirMAP; miRNATAP -0.32 0 NA
70 hsa-miR-7-1-3p BDNF -0.46 0.6659 0.5 0.16933 MirTarget -0.34 4.0E-5 NA
71 hsa-miR-146b-5p BRAF -0.4 0.83751 -0.04 0.94896 miRanda -0.12 0.00232 21874046; 26883911; 20406109; 21537871 Additionally the activation of thyroid most common oncogenes RET/PTC3 and BRAF in PCCL3 cells upregulated miR-146b-5p expression;miR-146b-5p positively regulates migration and invasion of thyroid normal and tumor follicular cells independently from their original mutation either BRAF or RET/PTC through a mechanism that involves the actin cytoskeleton but not an increased capacity of matrix degradation;The miR-146b expression levels in PTCs with BRAF mutation were significantly higher than those without this mutation p < 0.0001;Among BRAF-positive tumors overexpression of miR-146b was associated with aggressive behavior suggesting that it may further refine the prognostic importance of BRAF
72 hsa-miR-199a-5p BRAF 0.16 0.9358 -0.04 0.94896 miRanda -0.1 0.00848 NA
73 hsa-miR-199b-5p BRAF -0.04 0.97717 -0.04 0.94896 miRanda -0.12 0.0002 NA
74 hsa-miR-130b-5p CACNA1A -0.65 0.3791 0.1 0.85309 mirMAP -0.38 7.0E-5 NA
75 hsa-miR-16-2-3p CACNA1A -0.37 0.54685 0.1 0.85309 mirMAP -0.29 0.00148 NA
76 hsa-miR-188-5p CACNA1A -0.57 0.32482 0.1 0.85309 PITA -0.25 0.00064 NA
77 hsa-miR-339-5p CACNA1A -0.3 0.71291 0.1 0.85309 mirMAP -0.22 0.00625 NA
78 hsa-miR-590-3p CACNA1A -0.28 0.59127 0.1 0.85309 miRanda -0.27 0.00123 NA
79 hsa-miR-92a-1-5p CACNA1A -0.11 0.84853 0.1 0.85309 mirMAP -0.25 0.00168 NA
80 hsa-miR-107 CACNA1B -0.04 0.98836 0.76 0.45307 miRanda -1.29 0 NA
81 hsa-miR-141-3p CACNA1B -0.32 0.87774 0.76 0.45307 mirMAP -0.6 2.0E-5 NA
82 hsa-miR-185-3p CACNA1B 0.1 0.85691 0.76 0.45307 MirTarget -0.53 0.00216 NA
83 hsa-miR-18a-5p CACNA1B -0.5 0.61264 0.76 0.45307 mirMAP -0.43 0.00043 NA
84 hsa-miR-18b-5p CACNA1B -0.05 0.89998 0.76 0.45307 mirMAP -0.36 0.00275 NA
85 hsa-miR-197-3p CACNA1B -0.46 0.79492 0.76 0.45307 mirMAP -0.53 0.00426 NA
86 hsa-miR-200a-3p CACNA1B -0.37 0.85106 0.76 0.45307 mirMAP -0.39 0.0049 NA
87 hsa-miR-335-3p CACNA1B -0.24 0.8845 0.76 0.45307 mirMAP -0.58 0.00017 NA
88 hsa-miR-362-3p CACNA1B -0.72 0.03459 0.76 0.45307 MirTarget; miRNATAP -0.39 0.00442 NA
89 hsa-miR-429 CACNA1B -0.46 0.80624 0.76 0.45307 miRNATAP -0.41 0.00197 NA
90 hsa-miR-589-3p CACNA1B -0.84 0.0112 0.76 0.45307 MirTarget -0.57 1.0E-5 NA
91 hsa-miR-590-3p CACNA1B -0.28 0.59127 0.76 0.45307 miRanda -0.64 0 NA
92 hsa-miR-7-1-3p CACNA1B -0.46 0.6659 0.76 0.45307 MirTarget -0.57 0.0006 NA
93 hsa-miR-940 CACNA1B -0.23 0.68006 0.76 0.45307 MirTarget -0.33 0.00582 NA
94 hsa-let-7f-1-3p CACNA1C -0.31 0.69341 0.62 0.47829 MirTarget -0.54 0.00016 NA
95 hsa-miR-107 CACNA1C -0.04 0.98836 0.62 0.47829 miRNATAP -0.64 5.0E-5 NA
96 hsa-miR-1254 CACNA1C -0.49 0.19552 0.62 0.47829 PITA; miRNATAP -0.38 0 NA
97 hsa-miR-148b-5p CACNA1C -0.24 0.43926 0.62 0.47829 mirMAP -0.4 0 NA
98 hsa-miR-186-5p CACNA1C -0.32 0.85413 0.62 0.47829 mirMAP -0.7 0 NA
99 hsa-miR-192-5p CACNA1C -0.12 0.97293 0.62 0.47829 mirMAP -0.41 0 NA
100 hsa-miR-1976 CACNA1C -0.28 0.707 0.62 0.47829 MirTarget -0.48 1.0E-5 NA
101 hsa-miR-19a-3p CACNA1C -0.21 0.84464 0.62 0.47829 MirTarget -0.5 0 NA
102 hsa-miR-19b-1-5p CACNA1C -0.01 0.98851 0.62 0.47829 MirTarget -0.52 0 NA
103 hsa-miR-19b-3p CACNA1C -0.03 0.98666 0.62 0.47829 MirTarget -0.45 0 NA
104 hsa-miR-200b-3p CACNA1C -0.43 0.86396 0.62 0.47829 MirTarget; TargetScan -0.29 0.00159 NA
105 hsa-miR-200c-3p CACNA1C -0.44 0.88712 0.62 0.47829 MirTarget -0.51 0 NA
106 hsa-miR-26b-5p CACNA1C -0.02 0.99038 0.62 0.47829 MirTarget; miRNATAP -0.34 0.00687 NA
107 hsa-miR-29a-3p CACNA1C 0.01 0.99698 0.62 0.47829 MirTarget -0.35 0.00503 NA
108 hsa-miR-29b-3p CACNA1C -0.1 0.95899 0.62 0.47829 MirTarget -0.46 0 NA
109 hsa-miR-30d-5p CACNA1C -0.17 0.95173 0.62 0.47829 mirMAP -0.32 0.00784 NA
110 hsa-miR-330-5p CACNA1C -0.28 0.81569 0.62 0.47829 miRanda -0.41 0.00081 NA
111 hsa-miR-33a-5p CACNA1C -0.21 0.85331 0.62 0.47829 MirTarget -0.19 0.00016 NA
112 hsa-miR-33b-5p CACNA1C -0.16 0.73744 0.62 0.47829 MirTarget -0.17 0.0021 NA
113 hsa-miR-361-3p CACNA1C -0.29 0.84773 0.62 0.47829 MirTarget -0.39 0.00492 NA
114 hsa-miR-378a-5p CACNA1C -0.56 0.72488 0.62 0.47829 MirTarget -0.4 3.0E-5 NA
115 hsa-miR-421 CACNA1C -0.18 0.7347 0.62 0.47829 MirTarget; PITA; miRanda; miRNATAP -0.5 0 NA
116 hsa-miR-429 CACNA1C -0.46 0.80624 0.62 0.47829 MirTarget; PITA; miRanda; miRNATAP -0.3 5.0E-5 NA
117 hsa-miR-450b-5p CACNA1C -0.01 0.98315 0.62 0.47829 PITA; miRNATAP -0.31 0.00172 NA
118 hsa-miR-484 CACNA1C -0.18 0.88633 0.62 0.47829 PITA; miRNATAP -0.59 0 NA
119 hsa-miR-532-5p CACNA1C -0.35 0.87895 0.62 0.47829 PITA -0.54 0 NA
120 hsa-miR-542-3p CACNA1C 0.19 0.90925 0.62 0.47829 miRanda -0.48 2.0E-5 NA
121 hsa-miR-577 CACNA1C -1.06 0.32606 0.62 0.47829 PITA -0.2 3.0E-5 NA
122 hsa-miR-589-3p CACNA1C -0.84 0.0112 0.62 0.47829 MirTarget; mirMAP -0.53 0 NA
123 hsa-miR-660-5p CACNA1C -0.48 0.69408 0.62 0.47829 MirTarget -0.58 0 NA
124 hsa-miR-671-3p CACNA1C -0.44 0.24235 0.62 0.47829 miRNATAP -0.33 0.00091 NA
125 hsa-miR-7-1-3p CACNA1C -0.46 0.6659 0.62 0.47829 MirTarget -0.43 0 NA
126 hsa-miR-877-5p CACNA1C -0.32 0.43595 0.62 0.47829 MirTarget -0.3 1.0E-5 NA
127 hsa-miR-93-3p CACNA1C -0.44 0.5499 0.62 0.47829 mirMAP -0.47 0 NA
128 hsa-miR-96-5p CACNA1C 0.09 0.92309 0.62 0.47829 MirTarget; TargetScan -0.39 0 NA
129 hsa-miR-342-3p CACNA1D -0.37 0.77314 -0.25 0.78299 miRanda -0.29 0.00139 NA
130 hsa-miR-625-5p CACNA1D -0.69 0.21031 -0.25 0.78299 MirTarget -0.23 0.00062 NA
131 hsa-let-7f-5p CACNA1E 0.05 0.98728 -0.02 0.97264 miRNATAP -0.94 1.0E-5 NA
132 hsa-let-7g-5p CACNA1E -0.2 0.92299 -0.02 0.97264 miRNATAP -1.04 0 NA
133 hsa-miR-106a-5p CACNA1E -0.2 0.80221 -0.02 0.97264 mirMAP -0.46 0.00114 NA
134 hsa-miR-106b-5p CACNA1E -0.3 0.86929 -0.02 0.97264 mirMAP -0.88 0 NA
135 hsa-miR-1266-5p CACNA1E -0.75 0.4758 -0.02 0.97264 MirTarget -0.27 0.00933 NA
136 hsa-miR-1304-5p CACNA1E -0.5 0.16308 -0.02 0.97264 mirMAP -0.31 0.00343 NA
137 hsa-miR-130b-5p CACNA1E -0.65 0.3791 -0.02 0.97264 miRNATAP -0.41 0.00248 NA
138 hsa-miR-135b-5p CACNA1E 0.63 0.61003 -0.02 0.97264 miRNATAP -0.25 0.00407 NA
139 hsa-miR-141-3p CACNA1E -0.32 0.87774 -0.02 0.97264 MirTarget; TargetScan; miRNATAP -0.66 0 NA
140 hsa-miR-141-5p CACNA1E -0.35 0.86764 -0.02 0.97264 mirMAP -0.57 1.0E-5 NA
141 hsa-miR-148a-3p CACNA1E -0.1 0.97698 -0.02 0.97264 mirMAP -0.6 4.0E-5 NA
142 hsa-miR-148b-3p CACNA1E -0.2 0.91188 -0.02 0.97264 mirMAP -0.63 0.00226 NA
143 hsa-miR-148b-5p CACNA1E -0.24 0.43926 -0.02 0.97264 mirMAP -0.36 0.00524 NA
144 hsa-miR-15a-5p CACNA1E -0.07 0.96484 -0.02 0.97264 MirTarget -0.85 0 NA
145 hsa-miR-15b-5p CACNA1E -0.27 0.87097 -0.02 0.97264 MirTarget -0.58 0.00026 NA
146 hsa-miR-16-2-3p CACNA1E -0.37 0.54685 -0.02 0.97264 mirMAP -0.46 0.00034 NA
147 hsa-miR-16-5p CACNA1E 0.01 0.99448 -0.02 0.97264 MirTarget -0.75 0 NA
148 hsa-miR-17-3p CACNA1E 0.1 0.96011 -0.02 0.97264 miRNATAP -0.51 0.00035 NA
149 hsa-miR-17-5p CACNA1E -0.18 0.93454 -0.02 0.97264 mirMAP -0.56 0 NA
150 hsa-miR-182-5p CACNA1E -0.1 0.97338 -0.02 0.97264 mirMAP; miRNATAP -0.36 0.00397 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 63 404 1.458e-69 6.785e-66
2 INTRACELLULAR SIGNAL TRANSDUCTION 90 1572 2.286e-64 5.317e-61
3 PROTEIN PHOSPHORYLATION 74 944 1.837e-60 2.849e-57
4 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 93 1977 2.069e-59 2.407e-56
5 REGULATION OF MAPK CASCADE 63 660 1.119e-55 1.042e-52
6 PHOSPHORYLATION 74 1228 3.92e-52 3.04e-49
7 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 80 1656 7.954e-50 5.287e-47
8 POSITIVE REGULATION OF RESPONSE TO STIMULUS 82 1929 4.838e-47 2.814e-44
9 POSITIVE REGULATION OF MAPK CASCADE 50 470 1.158e-45 5.984e-43
10 POSITIVE REGULATION OF MOLECULAR FUNCTION 78 1791 5.933e-45 2.76e-42
11 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 60 876 3.576e-44 1.513e-41
12 REGULATION OF MAP KINASE ACTIVITY 42 319 5.408e-42 2.097e-39
13 REGULATION OF PROTEIN MODIFICATION PROCESS 74 1710 5.994e-42 2.145e-39
14 REGULATION OF PHOSPHORUS METABOLIC PROCESS 72 1618 2.116e-41 7.034e-39
15 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 46 470 3.939e-40 1.222e-37
16 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 60 1036 6.013e-40 1.646e-37
17 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 60 1036 6.013e-40 1.646e-37
18 POSITIVE REGULATION OF CELL COMMUNICATION 69 1532 1.084e-39 2.803e-37
19 REGULATION OF KINASE ACTIVITY 53 776 1.788e-38 4.379e-36
20 POSITIVE REGULATION OF KINASE ACTIVITY 45 482 2.714e-38 6.313e-36
21 POSITIVE REGULATION OF CATALYTIC ACTIVITY 67 1518 8.645e-38 1.915e-35
22 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 59 1135 1.44e-36 3.045e-34
23 REGULATION OF TRANSFERASE ACTIVITY 53 946 4.237e-34 8.572e-32
24 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 63 1492 4.663e-34 9.041e-32
25 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 45 616 1.428e-33 2.658e-31
26 ACTIVATION OF PROTEIN KINASE ACTIVITY 32 279 7.144e-30 1.279e-27
27 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 30 289 1.067e-26 1.839e-24
28 RESPONSE TO GROWTH FACTOR 35 475 4.955e-26 8.235e-24
29 STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 21 103 2.971e-25 4.767e-23
30 POSITIVE REGULATION OF MAP KINASE ACTIVITY 25 207 5.704e-24 8.847e-22
31 REGULATION OF CELL DEATH 52 1472 7.857e-24 1.179e-21
32 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 38 689 9.384e-24 1.364e-21
33 REGULATION OF RESPONSE TO STRESS 51 1468 5.295e-23 7.466e-21
34 JNK CASCADE 18 82 2.115e-22 2.894e-20
35 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 32 498 5.739e-22 7.63e-20
36 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 44 1142 2.232e-21 2.884e-19
37 REGULATION OF ERK1 AND ERK2 CASCADE 24 238 3.821e-21 4.805e-19
38 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 22 197 2.03e-20 2.485e-18
39 REGULATION OF CELL DIFFERENTIATION 48 1492 3.841e-20 4.583e-18
40 REGULATION OF TRANSPORT 52 1804 7.686e-20 8.94e-18
41 POSITIVE REGULATION OF HYDROLASE ACTIVITY 38 905 1.251e-19 1.419e-17
42 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 40 1021 1.295e-19 1.435e-17
43 RESPONSE TO ENDOGENOUS STIMULUS 46 1450 5.278e-19 5.711e-17
44 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 49 1672 6.827e-19 7.22e-17
45 CELL DEVELOPMENT 45 1426 1.775e-18 1.836e-16
46 POSITIVE REGULATION OF CELL DEATH 31 605 1.947e-18 1.969e-16
47 RESPONSE TO OXYGEN CONTAINING COMPOUND 44 1381 3.35e-18 3.316e-16
48 REGULATION OF HYDROLASE ACTIVITY 43 1327 4.872e-18 4.653e-16
49 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 44 1395 4.9e-18 4.653e-16
50 REGULATION OF IMMUNE SYSTEM PROCESS 44 1403 6.078e-18 5.656e-16
51 CARDIOVASCULAR SYSTEM DEVELOPMENT 34 788 6.654e-18 5.954e-16
52 CIRCULATORY SYSTEM DEVELOPMENT 34 788 6.654e-18 5.954e-16
53 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 50 1848 7.53e-18 6.611e-16
54 RESPONSE TO ABIOTIC STIMULUS 38 1024 8.072e-18 6.955e-16
55 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 19 172 1.155e-17 9.771e-16
56 VASCULATURE DEVELOPMENT 27 469 2.26e-17 1.878e-15
57 ACTIVATION OF MAPKK ACTIVITY 13 52 2.76e-17 2.253e-15
58 NEGATIVE REGULATION OF CELL COMMUNICATION 40 1192 2.942e-17 2.36e-15
59 REGULATION OF JNK CASCADE 18 159 5.598e-17 4.415e-15
60 REGULATION OF CELL PROLIFERATION 44 1496 6.685e-17 5.184e-15
61 TISSUE DEVELOPMENT 44 1518 1.148e-16 8.755e-15
62 RESPONSE TO EXTERNAL STIMULUS 48 1821 1.257e-16 9.436e-15
63 POSITIVE REGULATION OF CELL DIFFERENTIATION 33 823 1.924e-16 1.421e-14
64 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 22 323 8.512e-16 6.188e-14
65 POSITIVE REGULATION OF TRANSPORT 34 936 1.175e-15 8.409e-14
66 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 35 1008 1.604e-15 1.131e-13
67 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 18 193 1.802e-15 1.252e-13
68 CELLULAR RESPONSE TO STRESS 43 1565 1.942e-15 1.329e-13
69 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 16 138 2.246e-15 1.514e-13
70 ORGAN MORPHOGENESIS 32 841 2.619e-15 1.716e-13
71 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 40 1360 2.608e-15 1.716e-13
72 REGULATION OF GTPASE ACTIVITY 29 673 2.72e-15 1.758e-13
73 POSITIVE REGULATION OF GENE EXPRESSION 45 1733 2.781e-15 1.773e-13
74 RAS PROTEIN SIGNAL TRANSDUCTION 16 143 3.983e-15 2.504e-13
75 REGULATION OF IMMUNE RESPONSE 32 858 4.583e-15 2.843e-13
76 NEGATIVE REGULATION OF CELL DEATH 32 872 7.196e-15 4.406e-13
77 POSITIVE REGULATION OF CELL PROLIFERATION 31 814 7.534e-15 4.553e-13
78 CELL CELL SIGNALING 30 767 1.095e-14 6.532e-13
79 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 45 1805 1.234e-14 7.267e-13
80 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 33 957 1.483e-14 8.623e-13
81 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 20 297 2.392e-14 1.374e-12
82 REGULATION OF NEURON APOPTOTIC PROCESS 17 192 2.717e-14 1.542e-12
83 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 15 135 3.328e-14 1.866e-12
84 REGULATION OF CELLULAR RESPONSE TO STRESS 28 691 4.059e-14 2.248e-12
85 ACTIVATION OF MAPK ACTIVITY 15 137 4.151e-14 2.272e-12
86 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 21 352 5.574e-14 3.016e-12
87 FC RECEPTOR SIGNALING PATHWAY 17 206 8.714e-14 4.656e-12
88 REGULATION OF CELLULAR COMPONENT MOVEMENT 29 771 8.806e-14 4.656e-12
89 TUBE DEVELOPMENT 25 552 9.509e-14 4.972e-12
90 BLOOD VESSEL MORPHOGENESIS 21 364 1.073e-13 5.549e-12
91 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 21 365 1.132e-13 5.789e-12
92 LOCOMOTION 34 1114 1.843e-13 9.319e-12
93 REGULATION OF NEURON DEATH 18 252 1.891e-13 9.459e-12
94 INOSITOL LIPID MEDIATED SIGNALING 14 124 1.976e-13 9.782e-12
95 LIPID PHOSPHORYLATION 13 99 2.036e-13 9.971e-12
96 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 20 337 2.57e-13 1.246e-11
97 CELL DEATH 32 1001 3.166e-13 1.519e-11
98 MEMBRANE DEPOLARIZATION 11 61 4.118e-13 1.955e-11
99 HEAD DEVELOPMENT 27 709 5.37e-13 2.524e-11
100 GLYCEROLIPID METABOLIC PROCESS 20 356 7.114e-13 3.31e-11
101 SALIVARY GLAND DEVELOPMENT 9 32 7.612e-13 3.507e-11
102 PHOSPHOLIPID METABOLIC PROCESS 20 364 1.072e-12 4.891e-11
103 RESPONSE TO WOUNDING 24 563 1.151e-12 5.199e-11
104 FC EPSILON RECEPTOR SIGNALING PATHWAY 14 142 1.309e-12 5.859e-11
105 HEART DEVELOPMENT 22 466 1.494e-12 6.622e-11
106 REGULATION OF CELLULAR LOCALIZATION 35 1277 1.685e-12 7.396e-11
107 WOUND HEALING 22 470 1.77e-12 7.698e-11
108 REGULATION OF TRANSMEMBRANE TRANSPORT 21 426 2.225e-12 9.588e-11
109 PEPTIDYL SERINE MODIFICATION 14 148 2.319e-12 9.849e-11
110 IMMUNE SYSTEM DEVELOPMENT 24 582 2.328e-12 9.849e-11
111 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 33 1152 2.56e-12 1.073e-10
112 EMBRYO DEVELOPMENT 29 894 3.496e-12 1.452e-10
113 PEPTIDYL AMINO ACID MODIFICATION 28 841 4.744e-12 1.953e-10
114 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 9 39 5.518e-12 2.252e-10
115 MORPHOGENESIS OF AN EPITHELIUM 20 400 6.023e-12 2.437e-10
116 IMMUNE SYSTEM PROCESS 43 1984 6.779e-12 2.719e-10
117 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 14 162 8.006e-12 3.184e-10
118 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 27 799 8.627e-12 3.402e-10
119 POSITIVE REGULATION OF GROWTH 16 238 1.127e-11 4.338e-10
120 CENTRAL NERVOUS SYSTEM DEVELOPMENT 28 872 1.116e-11 4.338e-10
121 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 18 321 1.128e-11 4.338e-10
122 EPITHELIUM DEVELOPMENT 29 945 1.347e-11 5.136e-10
123 REGULATION OF EPITHELIAL CELL PROLIFERATION 17 285 1.655e-11 6.262e-10
124 REGULATION OF SECRETION 25 699 1.697e-11 6.369e-10
125 RESPONSE TO LIPID 28 888 1.711e-11 6.369e-10
126 EXOCRINE SYSTEM DEVELOPMENT 9 45 2.227e-11 8.224e-10
127 REGULATION OF CELL DEVELOPMENT 27 836 2.424e-11 8.881e-10
128 ANGIOGENESIS 17 293 2.563e-11 9.317e-10
129 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 22 541 2.775e-11 9.932e-10
130 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 22 541 2.775e-11 9.932e-10
131 NEGATIVE REGULATION OF MAPK CASCADE 13 145 2.896e-11 1.029e-09
132 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 33 1275 3.875e-11 1.366e-09
133 MODULATION OF SYNAPTIC TRANSMISSION 17 301 3.915e-11 1.37e-09
134 REGULATION OF CELL MORPHOGENESIS 22 552 4.091e-11 1.42e-09
135 GLAND DEVELOPMENT 19 395 4.135e-11 1.425e-09
136 CALCIUM ION TRANSPORT 15 223 5.101e-11 1.745e-09
137 PEPTIDYL TYROSINE MODIFICATION 14 186 5.187e-11 1.762e-09
138 ACTION POTENTIAL 11 94 5.59e-11 1.885e-09
139 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 13 154 6.209e-11 2.078e-09
140 PROTEIN DEPHOSPHORYLATION 14 190 6.898e-11 2.292e-09
141 GLAND MORPHOGENESIS 11 97 7.912e-11 2.611e-09
142 REGULATION OF PROTEIN LOCALIZATION 28 950 8.215e-11 2.692e-09
143 RESPONSE TO RADIATION 19 413 8.851e-11 2.88e-09
144 CALCIUM ION TRANSMEMBRANE TRANSPORT 13 159 9.286e-11 3.001e-09
145 NEUROGENESIS 34 1402 1.056e-10 3.388e-09
146 POSITIVE REGULATION OF LOCOMOTION 19 420 1.178e-10 3.753e-09
147 RESPONSE TO LIGHT STIMULUS 16 280 1.282e-10 4.057e-09
148 POSITIVE REGULATION OF CELL DIVISION 12 132 1.464e-10 4.604e-09
149 REGULATION OF ION TRANSPORT 22 592 1.558e-10 4.864e-09
150 PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING 7 23 1.581e-10 4.903e-09
151 REGULATION OF EPITHELIAL CELL MIGRATION 13 166 1.594e-10 4.912e-09
152 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 28 983 1.798e-10 5.505e-09
153 RESPONSE TO DRUG 19 431 1.824e-10 5.547e-09
154 LIPID MODIFICATION 14 210 2.609e-10 7.873e-09
155 REGULATION OF PROTEIN SECRETION 18 389 2.623e-10 7.873e-09
156 GLYCEROLIPID BIOSYNTHETIC PROCESS 14 211 2.778e-10 8.287e-09
157 NEURON DIFFERENTIATION 26 874 3.548e-10 1.052e-08
158 FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 10 84 3.628e-10 1.068e-08
159 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 12 144 4.049e-10 1.185e-08
160 PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING 7 26 4.168e-10 1.205e-08
161 INACTIVATION OF MAPK ACTIVITY 7 26 4.168e-10 1.205e-08
162 CELL ACTIVATION 21 568 4.664e-10 1.34e-08
163 REGULATION OF ORGANELLE ORGANIZATION 30 1178 5.305e-10 1.514e-08
164 REGULATION OF PROTEIN IMPORT 13 183 5.359e-10 1.521e-08
165 REGULATION OF PHOSPHOLIPASE ACTIVITY 9 64 6.186e-10 1.744e-08
166 DIVALENT INORGANIC CATION TRANSPORT 15 268 6.689e-10 1.875e-08
167 REGULATION OF CELLULAR COMPONENT BIOGENESIS 24 767 6.831e-10 1.903e-08
168 CELL PROJECTION ORGANIZATION 26 902 6.948e-10 1.924e-08
169 CELL MOTILITY 25 835 7.138e-10 1.954e-08
170 LOCALIZATION OF CELL 25 835 7.138e-10 1.954e-08
171 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 14 228 7.687e-10 2.092e-08
172 REGULATION OF CELL DIVISION 15 272 8.207e-10 2.22e-08
173 RESPONSE TO BACTERIUM 20 528 8.302e-10 2.233e-08
174 POSITIVE REGULATION OF CELL DEVELOPMENT 19 472 8.359e-10 2.235e-08
175 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 11 121 8.807e-10 2.342e-08
176 TISSUE MORPHOGENESIS 20 533 9.769e-10 2.554e-08
177 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 7 29 9.718e-10 2.554e-08
178 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 7 29 9.718e-10 2.554e-08
179 CONNECTIVE TISSUE DEVELOPMENT 13 194 1.1e-09 2.859e-08
180 PHOSPHOLIPID BIOSYNTHETIC PROCESS 14 235 1.14e-09 2.947e-08
181 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 26 926 1.211e-09 3.112e-08
182 PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING 6 17 1.227e-09 3.137e-08
183 REGULATION OF CELL ACTIVATION 19 484 1.267e-09 3.222e-08
184 RESPONSE TO NITROGEN COMPOUND 25 859 1.276e-09 3.228e-08
185 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 8 48 1.404e-09 3.513e-08
186 MUSCLE STRUCTURE DEVELOPMENT 18 432 1.401e-09 3.513e-08
187 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 25 867 1.542e-09 3.837e-08
188 PHOSPHATIDYLGLYCEROL METABOLIC PROCESS 7 31 1.618e-09 3.984e-08
189 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 11 128 1.61e-09 3.984e-08
190 SINGLE ORGANISM BEHAVIOR 17 384 1.67e-09 4.067e-08
191 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 8 49 1.669e-09 4.067e-08
192 SENSORY ORGAN DEVELOPMENT 19 493 1.717e-09 4.162e-08
193 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 11 129 1.75e-09 4.219e-08
194 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 9 73 2.068e-09 4.959e-08
195 REGULATION OF INTRACELLULAR TRANSPORT 21 621 2.304e-09 5.498e-08
196 REGULATION OF MEMBRANE POTENTIAL 16 343 2.466e-09 5.854e-08
197 ACTIN FILAMENT BASED PROCESS 18 450 2.666e-09 6.265e-08
198 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 6 19 2.659e-09 6.265e-08
199 REGULATION OF CALCIUM ION TRANSPORT 13 209 2.73e-09 6.384e-08
200 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 10 103 2.77e-09 6.443e-08
201 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 11 135 2.841e-09 6.576e-08
202 REGULATION OF CELL ADHESION 21 629 2.89e-09 6.658e-08
203 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 12 171 2.927e-09 6.709e-08
204 POSITIVE REGULATION OF PROTEIN IMPORT 10 104 3.046e-09 6.948e-08
205 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 8 53 3.203e-09 7.27e-08
206 REGULATION OF GROWTH 21 633 3.233e-09 7.303e-08
207 CELLULAR COMPONENT MORPHOGENESIS 25 900 3.289e-09 7.394e-08
208 STRIATED MUSCLE CELL DIFFERENTIATION 12 173 3.341e-09 7.474e-08
209 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 19 514 3.403e-09 7.577e-08
210 GROWTH 17 410 4.465e-09 9.893e-08
211 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 13 218 4.55e-09 1.003e-07
212 REGULATION OF APOPTOTIC SIGNALING PATHWAY 16 363 5.534e-09 1.215e-07
213 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 26 1004 6.525e-09 1.425e-07
214 REGULATION OF LIPASE ACTIVITY 9 83 6.599e-09 1.435e-07
215 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 12 184 6.717e-09 1.454e-07
216 NEGATIVE REGULATION OF PHOSPHORYLATION 17 422 6.86e-09 1.478e-07
217 RESPONSE TO INORGANIC SUBSTANCE 18 479 7.066e-09 1.515e-07
218 EMBRYONIC MORPHOGENESIS 19 539 7.363e-09 1.572e-07
219 TUBE MORPHOGENESIS 15 323 8.512e-09 1.808e-07
220 NEURON PROJECTION DEVELOPMENT 19 545 8.804e-09 1.862e-07
221 RESPONSE TO FIBROBLAST GROWTH FACTOR 10 116 8.866e-09 1.867e-07
222 REGULATION OF PHOSPHOLIPASE C ACTIVITY 7 39 9.034e-09 1.893e-07
223 EYE DEVELOPMENT 15 326 9.635e-09 2.01e-07
224 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 14 278 9.884e-09 2.053e-07
225 REGULATION OF VASCULATURE DEVELOPMENT 13 233 1.013e-08 2.094e-07
226 PROTEIN AUTOPHOSPHORYLATION 12 192 1.084e-08 2.232e-07
227 ORGANOPHOSPHATE METABOLIC PROCESS 24 885 1.127e-08 2.311e-07
228 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 19 554 1.146e-08 2.327e-07
229 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 17 437 1.15e-08 2.327e-07
230 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 20 616 1.142e-08 2.327e-07
231 MUSCLE CELL DIFFERENTIATION 13 237 1.241e-08 2.5e-07
232 NEURON DEVELOPMENT 21 687 1.353e-08 2.713e-07
233 DEPHOSPHORYLATION 14 286 1.416e-08 2.827e-07
234 RESPIRATORY SYSTEM DEVELOPMENT 12 197 1.446e-08 2.875e-07
235 POSITIVE REGULATION OF IMMUNE RESPONSE 19 563 1.484e-08 2.938e-07
236 PHOSPHATIDYLCHOLINE METABOLIC PROCESS 8 64 1.499e-08 2.956e-07
237 REGULATION OF HEART GROWTH 7 42 1.557e-08 3.057e-07
238 POSITIVE REGULATION OF LIPASE ACTIVITY 8 66 1.923e-08 3.76e-07
239 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 10 126 1.974e-08 3.842e-07
240 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 18 513 2.032e-08 3.939e-07
241 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 14 296 2.183e-08 4.214e-07
242 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 9 95 2.197e-08 4.225e-07
243 BEHAVIOR 18 516 2.221e-08 4.253e-07
244 COGNITION 13 251 2.455e-08 4.681e-07
245 MORPHOGENESIS OF A BRANCHING STRUCTURE 11 167 2.647e-08 5.027e-07
246 EMBRYONIC ORGAN DEVELOPMENT 16 406 2.668e-08 5.047e-07
247 POSITIVE REGULATION OF HEART GROWTH 6 27 2.771e-08 5.198e-07
248 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 6 27 2.771e-08 5.198e-07
249 RESPONSE TO CARBOHYDRATE 11 168 2.816e-08 5.262e-07
250 PEPTIDYL THREONINE MODIFICATION 7 46 3.018e-08 5.617e-07
251 POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 10 132 3.085e-08 5.719e-07
252 NEGATIVE REGULATION OF NEURON DEATH 11 171 3.381e-08 6.242e-07
253 PEPTIDYL TYROSINE DEPHOSPHORYLATION 9 100 3.454e-08 6.352e-07
254 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 15 360 3.6e-08 6.595e-07
255 CELL GROWTH 10 135 3.825e-08 6.979e-07
256 POSITIVE REGULATION OF DEFENSE RESPONSE 15 364 4.163e-08 7.567e-07
257 REGULATION OF ORGAN GROWTH 8 73 4.319e-08 7.82e-07
258 REGULATION OF CYTOPLASMIC TRANSPORT 17 481 4.666e-08 8.415e-07
259 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 12 220 4.921e-08 8.841e-07
260 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 34 1784 5.012e-08 8.97e-07
261 SYSTEM PROCESS 34 1785 5.081e-08 9.059e-07
262 RESPONSE TO BIOTIC STIMULUS 23 886 5.272e-08 9.364e-07
263 REGULATION OF SYNAPTIC PLASTICITY 10 140 5.409e-08 9.569e-07
264 FACE DEVELOPMENT 7 50 5.502e-08 9.698e-07
265 RESPONSE TO HORMONE 23 893 6.081e-08 1.068e-06
266 PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING 5 16 6.422e-08 1.123e-06
267 REGULATION OF METAL ION TRANSPORT 14 325 6.995e-08 1.219e-06
268 REGULATION OF DEFENSE RESPONSE 21 759 7.42e-08 1.288e-06
269 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 12 229 7.641e-08 1.322e-06
270 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 6 32 8.241e-08 1.42e-06
271 CARTILAGE DEVELOPMENT 10 147 8.589e-08 1.475e-06
272 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 12 232 8.808e-08 1.507e-06
273 PHOSPHATIDYLSERINE ACYL CHAIN REMODELING 5 17 9.047e-08 1.542e-06
274 REGULATION OF LIPID METABOLIC PROCESS 13 282 9.613e-08 1.632e-06
275 RESPONSE TO ORGANIC CYCLIC COMPOUND 23 917 9.808e-08 1.66e-06
276 REGULATION OF JUN KINASE ACTIVITY 8 81 9.861e-08 1.662e-06
277 REGULATION OF BINDING 13 283 1.002e-07 1.682e-06
278 REGULATION OF ENDOTHELIAL CELL MIGRATION 9 114 1.084e-07 1.811e-06
279 CRANIAL SKELETAL SYSTEM DEVELOPMENT 7 55 1.086e-07 1.811e-06
280 REGULATION OF MUSCLE CELL DIFFERENTIATION 10 152 1.177e-07 1.957e-06
281 REGULATION OF MESENCHYMAL CELL PROLIFERATION 6 34 1.209e-07 2.002e-06
282 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 7 56 1.234e-07 2.036e-06
283 INOSITOL PHOSPHATE MEDIATED SIGNALING 5 18 1.246e-07 2.048e-06
284 APOPTOTIC SIGNALING PATHWAY 13 289 1.277e-07 2.092e-06
285 LEUKOCYTE DIFFERENTIATION 13 292 1.439e-07 2.345e-06
286 ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS 8 85 1.441e-07 2.345e-06
287 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 10 156 1.503e-07 2.436e-06
288 REGULATION OF TRANSPORTER ACTIVITY 11 198 1.512e-07 2.443e-06
289 SECRETION 18 588 1.583e-07 2.54e-06
290 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 8 86 1.58e-07 2.54e-06
291 TAXIS 16 464 1.666e-07 2.663e-06
292 SKELETAL SYSTEM MORPHOGENESIS 11 201 1.76e-07 2.805e-06
293 REGULATION OF STEM CELL PROLIFERATION 8 88 1.891e-07 3.003e-06
294 CHONDROCYTE DIFFERENTIATION 7 60 2.007e-07 3.177e-06
295 MULTICELLULAR ORGANISMAL SIGNALING 9 123 2.086e-07 3.29e-06
296 REGULATION OF RESPONSE TO WOUNDING 15 413 2.144e-07 3.371e-06
297 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 7 61 2.254e-07 3.52e-06
298 CALCIUM MEDIATED SIGNALING 8 90 2.254e-07 3.52e-06
299 POSITIVE REGULATION OF ORGAN GROWTH 6 38 2.426e-07 3.775e-06
300 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 7 62 2.526e-07 3.918e-06
301 REGULATION OF PEPTIDE TRANSPORT 12 256 2.558e-07 3.955e-06
302 REGULATION OF PEPTIDE SECRETION 11 209 2.607e-07 4.017e-06
303 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 12 258 2.781e-07 4.271e-06
304 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 20 750 2.823e-07 4.321e-06
305 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 6 39 2.85e-07 4.348e-06
306 SKIN DEVELOPMENT 11 211 2.868e-07 4.361e-06
307 ACTIVATION OF IMMUNE RESPONSE 15 427 3.282e-07 4.974e-06
308 REGULATION OF HEMOPOIESIS 13 314 3.31e-07 5e-06
309 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 6 40 3.334e-07 5.02e-06
310 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 14 370 3.408e-07 5.115e-06
311 LEARNING 9 131 3.575e-07 5.331e-06
312 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 9 131 3.575e-07 5.331e-06
313 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 14 372 3.636e-07 5.406e-06
314 REGULATION OF CELL PROJECTION ORGANIZATION 17 558 3.846e-07 5.7e-06
315 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 9 133 4.066e-07 6.007e-06
316 POSITIVE REGULATION OF NEURON DEATH 7 67 4.339e-07 6.369e-06
317 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 7 67 4.339e-07 6.369e-06
318 POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 6 42 4.504e-07 6.591e-06
319 NEUROTROPHIN SIGNALING PATHWAY 5 23 4.756e-07 6.937e-06
320 REGULATION OF CYTOSKELETON ORGANIZATION 16 502 4.781e-07 6.952e-06
321 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 24 1087 5.156e-07 7.473e-06
322 REGULATION OF SYSTEM PROCESS 16 507 5.452e-07 7.879e-06
323 MUSCLE TISSUE DEVELOPMENT 12 275 5.496e-07 7.917e-06
324 NEGATIVE REGULATION OF CELL PROLIFERATION 18 643 5.855e-07 8.409e-06
325 ORGANOPHOSPHATE BIOSYNTHETIC PROCESS 15 450 6.371e-07 9.105e-06
326 REGULATION OF MUSCLE TISSUE DEVELOPMENT 8 103 6.406e-07 9.105e-06
327 RESPONSE TO METAL ION 13 333 6.438e-07 9.105e-06
328 REGULATION OF MUSCLE ORGAN DEVELOPMENT 8 103 6.406e-07 9.105e-06
329 DEVELOPMENTAL GROWTH 13 333 6.438e-07 9.105e-06
330 SKIN EPIDERMIS DEVELOPMENT 7 71 6.483e-07 9.141e-06
331 SKELETAL SYSTEM DEVELOPMENT 15 455 7.319e-07 1.02e-05
332 REGULATION OF CELL CYCLE 22 949 7.32e-07 1.02e-05
333 ACTIVATION OF MAPKKK ACTIVITY 4 11 7.306e-07 1.02e-05
334 POSITIVE REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS 4 11 7.306e-07 1.02e-05
335 REGULATION OF LEUKOCYTE DIFFERENTIATION 11 232 7.367e-07 1.023e-05
336 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 25 7.426e-07 1.028e-05
337 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 6 46 7.86e-07 1.082e-05
338 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 6 46 7.86e-07 1.082e-05
339 CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 7 74 8.621e-07 1.183e-05
340 MYELOID CELL DIFFERENTIATION 10 189 8.873e-07 1.214e-05
341 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 6 47 8.959e-07 1.222e-05
342 REGULATION OF DEVELOPMENTAL GROWTH 12 289 9.288e-07 1.263e-05
343 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 10 190 9.311e-07 1.263e-05
344 DIGESTIVE SYSTEM DEVELOPMENT 9 148 1.002e-06 1.351e-05
345 POSITIVE REGULATION OF CELL GROWTH 9 148 1.002e-06 1.351e-05
346 REPRODUCTION 26 1297 1.013e-06 1.362e-05
347 REGULATION OF LIPID KINASE ACTIVITY 6 48 1.018e-06 1.365e-05
348 REGULATION OF NEURON PROJECTION DEVELOPMENT 14 408 1.094e-06 1.463e-05
349 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 17 602 1.097e-06 1.463e-05
350 REGULATION OF ORGAN MORPHOGENESIS 11 242 1.116e-06 1.483e-05
351 RHYTHMIC PROCESS 12 298 1.281e-06 1.698e-05
352 LYMPHOCYTE HOMEOSTASIS 6 50 1.303e-06 1.723e-05
353 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 9 153 1.323e-06 1.744e-05
354 UROGENITAL SYSTEM DEVELOPMENT 12 299 1.327e-06 1.744e-05
355 NECROTIC CELL DEATH 5 28 1.351e-06 1.76e-05
356 ERBB SIGNALING PATHWAY 7 79 1.349e-06 1.76e-05
357 PHOSPHATIDYLSERINE METABOLIC PROCESS 5 28 1.351e-06 1.76e-05
358 FOREBRAIN DEVELOPMENT 13 357 1.402e-06 1.817e-05
359 CELLULAR MACROMOLECULE LOCALIZATION 25 1234 1.399e-06 1.817e-05
360 REGULATION OF NEUROTRANSMITTER SECRETION 6 51 1.468e-06 1.893e-05
361 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 6 51 1.468e-06 1.893e-05
362 CELLULAR LIPID METABOLIC PROCESS 21 913 1.528e-06 1.958e-05
363 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 12 303 1.524e-06 1.958e-05
364 NEGATIVE REGULATION OF KINASE ACTIVITY 11 250 1.533e-06 1.96e-05
365 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 4 13 1.566e-06 1.996e-05
366 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 8 116 1.586e-06 2.016e-05
367 REGULATION OF FIBROBLAST PROLIFERATION 7 81 1.599e-06 2.028e-05
368 RESPONSE TO ALCOHOL 13 362 1.636e-06 2.068e-05
369 SECRETION BY CELL 15 486 1.661e-06 2.089e-05
370 REGULATION OF CELLULAR PROTEIN LOCALIZATION 16 552 1.66e-06 2.089e-05
371 NEGATIVE REGULATION OF MOLECULAR FUNCTION 23 1079 1.678e-06 2.105e-05
372 EPIDERMIS DEVELOPMENT 11 253 1.722e-06 2.154e-05
373 REGULATION OF NEURON DIFFERENTIATION 16 554 1.74e-06 2.156e-05
374 REGULATION OF HOMOTYPIC CELL CELL ADHESION 12 307 1.747e-06 2.156e-05
375 NEGATIVE REGULATION OF CELL ACTIVATION 9 158 1.729e-06 2.156e-05
376 CARDIAC CONDUCTION 7 82 1.738e-06 2.156e-05
377 REGULATION OF PROTEIN TARGETING 12 307 1.747e-06 2.156e-05
378 HOMEOSTATIC PROCESS 26 1337 1.783e-06 2.195e-05
379 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 6 53 1.851e-06 2.266e-05
380 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 6 53 1.851e-06 2.266e-05
381 HAIR CYCLE 7 83 1.888e-06 2.299e-05
382 MOLTING CYCLE 7 83 1.888e-06 2.299e-05
383 SECOND MESSENGER MEDIATED SIGNALING 9 160 1.919e-06 2.331e-05
384 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 13 368 1.962e-06 2.377e-05
385 IN UTERO EMBRYONIC DEVELOPMENT 12 311 1.999e-06 2.415e-05
386 PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 8 120 2.049e-06 2.47e-05
387 POSITIVE REGULATION OF SECRETION 13 370 2.082e-06 2.504e-05
388 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 10 208 2.114e-06 2.535e-05
389 REGULATION OF CYTOKINE PRODUCTION 16 563 2.142e-06 2.563e-05
390 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 4 14 2.18e-06 2.589e-05
391 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 4 14 2.18e-06 2.589e-05
392 REGULATION OF PROTEIN KINASE B SIGNALING 8 121 2.181e-06 2.589e-05
393 RESPONSE TO STEROID HORMONE 15 497 2.188e-06 2.591e-05
394 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 55 2.31e-06 2.728e-05
395 POSITIVE REGULATION OF PROTEIN SECRETION 10 211 2.404e-06 2.831e-05
396 REGULATION OF HORMONE SECRETION 11 262 2.416e-06 2.839e-05
397 CELLULAR CHEMICAL HOMEOSTASIS 16 570 2.511e-06 2.943e-05
398 AGING 11 264 2.6e-06 3.032e-05
399 RESPONSE TO CYTOKINE 18 714 2.598e-06 3.032e-05
400 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 10 213 2.616e-06 3.043e-05
401 REGULATION OF CELL CELL ADHESION 13 380 2.791e-06 3.239e-05
402 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 7 88 2.803e-06 3.245e-05
403 REGULATION OF PROTEIN BINDING 9 168 2.872e-06 3.309e-05
404 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 13 381 2.873e-06 3.309e-05
405 AMMONIUM ION METABOLIC PROCESS 9 169 3.015e-06 3.464e-05
406 RESPONSE TO HEAT 7 89 3.025e-06 3.467e-05
407 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 5 33 3.171e-06 3.616e-05
408 PHOSPHATIDIC ACID METABOLIC PROCESS 5 33 3.171e-06 3.616e-05
409 RESPONSE TO ESTROGEN 10 218 3.219e-06 3.662e-05
410 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 19 801 3.254e-06 3.693e-05
411 REGULATION OF LIPID BIOSYNTHETIC PROCESS 8 128 3.327e-06 3.757e-05
412 MUSCLE CELL DEVELOPMENT 8 128 3.327e-06 3.757e-05
413 REGULATION OF HEART CONTRACTION 10 221 3.636e-06 4.096e-05
414 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 6 60 3.877e-06 4.347e-05
415 LEUKOCYTE HOMEOSTASIS 6 60 3.877e-06 4.347e-05
416 AMINE METABOLIC PROCESS 8 131 3.955e-06 4.423e-05
417 HOMEOSTASIS OF NUMBER OF CELLS 9 175 4.014e-06 4.479e-05
418 REGULATED EXOCYTOSIS 10 224 4.099e-06 4.563e-05
419 POSITIVE REGULATION OF STEM CELL PROLIFERATION 6 61 4.275e-06 4.747e-05
420 ALDITOL PHOSPHATE METABOLIC PROCESS 5 35 4.289e-06 4.752e-05
421 REGULATION OF VESICLE MEDIATED TRANSPORT 14 462 4.646e-06 5.135e-05
422 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 7 95 4.685e-06 5.166e-05
423 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 11 282 4.894e-06 5.383e-05
424 HEAD MORPHOGENESIS 5 36 4.953e-06 5.435e-05
425 MYELOID LEUKOCYTE DIFFERENTIATION 7 96 5.024e-06 5.501e-05
426 REGULATION OF CHEMOTAXIS 9 180 5.052e-06 5.518e-05
427 REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS 4 17 5.1e-06 5.531e-05
428 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 4 17 5.1e-06 5.531e-05
429 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 4 17 5.1e-06 5.531e-05
430 NEURON PROJECTION MORPHOGENESIS 13 402 5.149e-06 5.572e-05
431 POSITIVE REGULATION OF JUN KINASE ACTIVITY 6 63 5.172e-06 5.583e-05
432 REGULATION OF NEUROTRANSMITTER TRANSPORT 6 64 5.674e-06 6.111e-05
433 CARDIAC MUSCLE CELL ACTION POTENTIAL 5 37 5.695e-06 6.119e-05
434 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 13 406 5.73e-06 6.144e-05
435 REGULATION OF MYELOID CELL DIFFERENTIATION 9 183 5.779e-06 6.182e-05
436 LIPID BIOSYNTHETIC PROCESS 15 539 5.855e-06 6.248e-05
437 REPRODUCTIVE SYSTEM DEVELOPMENT 13 408 6.042e-06 6.433e-05
438 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 7 99 6.167e-06 6.551e-05
439 POSITIVE REGULATION OF DNA METABOLIC PROCESS 9 185 6.313e-06 6.691e-05
440 POSITIVE REGULATION OF ION TRANSPORT 10 236 6.502e-06 6.875e-05
441 ACID SECRETION 6 66 6.798e-06 7.172e-05
442 LEUKOCYTE ACTIVATION 13 414 7.069e-06 7.441e-05
443 RESPONSE TO OXIDATIVE STRESS 12 352 7.102e-06 7.459e-05
444 ERBB2 SIGNALING PATHWAY 5 39 7.438e-06 7.777e-05
445 CELLULAR RESPONSE TO DRUG 6 67 7.424e-06 7.777e-05
446 REGULATION OF BLOOD CIRCULATION 11 295 7.504e-06 7.829e-05
447 NUCLEAR TRANSPORT 12 355 7.736e-06 8.053e-05
448 MESENCHYME DEVELOPMENT 9 190 7.833e-06 8.136e-05
449 RESPONSE TO REACTIVE OXYGEN SPECIES 9 191 8.172e-06 8.469e-05
450 RESPONSE TO CAMP 7 104 8.548e-06 8.819e-05
451 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 7 104 8.548e-06 8.819e-05
452 POSITIVE REGULATION OF AXONOGENESIS 6 69 8.816e-06 9.075e-05
453 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 5 41 9.573e-06 9.826e-05
454 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 6 70 9.587e-06 9.826e-05
455 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 7 106 9.693e-06 9.913e-05
456 RESPONSE TO TEMPERATURE STIMULUS 8 148 9.747e-06 9.945e-05
457 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 4 20 1.021e-05 0.0001038
458 MICROVILLUS ORGANIZATION 4 20 1.021e-05 0.0001038
459 CHEMICAL HOMEOSTASIS 19 874 1.129e-05 0.0001144
460 POSITIVE REGULATION OF CYTOKINE PRODUCTION 12 370 1.172e-05 0.0001185
461 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 8 152 1.185e-05 0.0001196
462 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 15 573 1.212e-05 0.000122
463 ESTABLISHMENT OF LOCALIZATION IN CELL 28 1676 1.233e-05 0.0001236
464 RESPONSE TO OXYGEN LEVELS 11 311 1.232e-05 0.0001236
465 NEURON MIGRATION 7 110 1.237e-05 0.0001237
466 PALLIUM DEVELOPMENT 8 153 1.243e-05 0.0001241
467 NECROPTOTIC PROCESS 4 21 1.255e-05 0.000125
468 REGULATION OF ACTIN FILAMENT BASED PROCESS 11 312 1.27e-05 0.0001262
469 NEGATIVE REGULATION OF GENE EXPRESSION 26 1493 1.302e-05 0.000129
470 POSITIVE REGULATION OF PEPTIDASE ACTIVITY 8 154 1.303e-05 0.000129
471 BODY MORPHOGENESIS 5 44 1.364e-05 0.0001348
472 POSITIVE REGULATION OF CELL ADHESION 12 376 1.376e-05 0.0001356
473 METAL ION TRANSPORT 15 582 1.455e-05 0.0001432
474 OVULATION CYCLE 7 113 1.475e-05 0.0001448
475 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 4 22 1.525e-05 0.0001489
476 LUNG MORPHOGENESIS 5 45 1.526e-05 0.0001489
477 SOMATIC STEM CELL DIVISION 4 22 1.525e-05 0.0001489
478 RESPONSE TO ACID CHEMICAL 11 319 1.561e-05 0.0001519
479 REGULATION OF HOMEOSTATIC PROCESS 13 447 1.597e-05 0.0001551
480 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 7 115 1.654e-05 0.0001593
481 NEPHRON DEVELOPMENT 7 115 1.654e-05 0.0001593
482 SINGLE ORGANISM CELLULAR LOCALIZATION 19 898 1.648e-05 0.0001593
483 RESPONSE TO CALCIUM ION 7 115 1.654e-05 0.0001593
484 NEUROLOGICAL SYSTEM PROCESS 23 1242 1.695e-05 0.0001629
485 RESPONSE TO MECHANICAL STIMULUS 9 210 1.746e-05 0.0001675
486 LIPID METABOLIC PROCESS 22 1158 1.791e-05 0.0001715
487 REGULATION OF METANEPHROS DEVELOPMENT 4 23 1.837e-05 0.0001755
488 THYMUS DEVELOPMENT 5 47 1.895e-05 0.0001806
489 BONE MORPHOGENESIS 6 79 1.93e-05 0.0001837
490 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 7 118 1.956e-05 0.0001857
491 POSITIVE REGULATION OF HEMOPOIESIS 8 163 1.968e-05 0.0001861
492 CELLULAR RESPONSE TO BIOTIC STIMULUS 8 163 1.968e-05 0.0001861
493 CELL PROLIFERATION 16 672 1.973e-05 0.0001862
494 REGULATION OF CELL GROWTH 12 391 2.026e-05 0.0001908
495 REGULATION OF MYOBLAST DIFFERENTIATION 5 48 2.103e-05 0.0001977
496 CELLULAR HOMEOSTASIS 16 676 2.12e-05 0.0001989
497 POSITIVE REGULATION OF CHEMOTAXIS 7 120 2.181e-05 0.0002042
498 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 6 81 2.228e-05 0.0002082
499 POSITIVE REGULATION OF CELL CYCLE 11 332 2.258e-05 0.0002105
500 CYTOSKELETON ORGANIZATION 18 838 2.3e-05 0.000214
501 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 7 122 2.428e-05 0.0002255
502 REGULATION OF AXONOGENESIS 8 168 2.446e-05 0.0002267
503 REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 4 25 2.595e-05 0.0002396
504 HISTONE PHOSPHORYLATION 4 25 2.595e-05 0.0002396
505 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 6 84 2.743e-05 0.0002528
506 POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 5 51 2.837e-05 0.0002607
507 KIDNEY EPITHELIUM DEVELOPMENT 7 125 2.841e-05 0.0002607
508 HEART PROCESS 6 85 2.935e-05 0.0002688
509 RESPONSE TO UV 7 126 2.99e-05 0.0002734
510 NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 5 52 3.121e-05 0.0002848
511 POSITIVE REGULATION OF DNA REPLICATION 6 86 3.137e-05 0.0002856
512 POSITIVE REGULATION OF BINDING 7 127 3.146e-05 0.0002859
513 TELENCEPHALON DEVELOPMENT 9 228 3.338e-05 0.0003028
514 RESPONSE TO CORTICOSTEROID 8 176 3.413e-05 0.000309
515 OVULATION CYCLE PROCESS 6 88 3.574e-05 0.0003223
516 REGULATION OF CATION CHANNEL ACTIVITY 6 88 3.574e-05 0.0003223
517 REGULATION OF OSSIFICATION 8 178 3.699e-05 0.000333
518 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 11 351 3.755e-05 0.0003373
519 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 9 232 3.823e-05 0.0003428
520 CELL PART MORPHOGENESIS 15 633 3.845e-05 0.0003432
521 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 7 131 3.84e-05 0.0003432
522 POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 8 179 3.85e-05 0.0003432
523 MESONEPHROS DEVELOPMENT 6 90 4.06e-05 0.0003612
524 REGULATION OF KIDNEY DEVELOPMENT 5 55 4.108e-05 0.0003648
525 POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 4 28 4.133e-05 0.0003649
526 REGULATION OF FIBROBLAST MIGRATION 4 28 4.133e-05 0.0003649
527 POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING 4 28 4.133e-05 0.0003649
528 REGULATION OF INNATE IMMUNE RESPONSE 11 357 4.379e-05 0.0003859
529 MESENCHYMAL CELL DIFFERENTIATION 7 134 4.438e-05 0.0003904
530 SYNAPTIC SIGNALING 12 424 4.463e-05 0.0003918
531 PROTEIN LOCALIZATION 28 1805 4.721e-05 0.0004137
532 EPIDERMIS MORPHOGENESIS 4 29 4.768e-05 0.0004147
533 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 4 29 4.768e-05 0.0004147
534 STEM CELL DIVISION 4 29 4.768e-05 0.0004147
535 CARDIAC MUSCLE CELL CONTRACTION 4 29 4.768e-05 0.0004147
536 CELL JUNCTION ORGANIZATION 8 185 4.864e-05 0.0004223
537 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 6 93 4.886e-05 0.0004229
538 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 5 57 4.889e-05 0.0004229
539 RESPONSE TO TOXIC SUBSTANCE 9 241 5.138e-05 0.0004435
540 POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 3 11 5.316e-05 0.0004564
541 NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION 3 11 5.316e-05 0.0004564
542 POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 3 11 5.316e-05 0.0004564
543 PLACENTA DEVELOPMENT 7 138 5.353e-05 0.0004587
544 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 4 30 5.472e-05 0.000468
545 RESPONSE TO ORGANOPHOSPHORUS 7 139 5.604e-05 0.0004784
546 CELLULAR RESPONSE TO NITROGEN COMPOUND 13 505 5.64e-05 0.0004806
547 REGULATION OF NEUROTRANSMITTER LEVELS 8 190 5.872e-05 0.0004977
548 CARDIAC MUSCLE TISSUE DEVELOPMENT 7 140 5.865e-05 0.0004977
549 STEM CELL DIFFERENTIATION 8 190 5.872e-05 0.0004977
550 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 9 246 6.02e-05 0.0005093
551 POSITIVE REGULATION OF NEURON DIFFERENTIATION 10 306 6.036e-05 0.0005097
552 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 4 31 6.248e-05 0.0005248
553 LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 4 31 6.248e-05 0.0005248
554 REGULATION OF PLATELET ACTIVATION 4 31 6.248e-05 0.0005248
555 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 16 740 6.26e-05 0.0005248
556 PLATELET ACTIVATION 7 142 6.416e-05 0.000537
557 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 6 98 6.557e-05 0.0005477
558 EXOCYTOSIS 10 310 6.726e-05 0.0005609
559 REGULATION OF PROTEIN COMPLEX ASSEMBLY 11 375 6.812e-05 0.000567
560 REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION 3 12 7.052e-05 0.0005818
561 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 3 12 7.052e-05 0.0005818
562 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 17 829 7.003e-05 0.0005818
563 POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 3 12 7.052e-05 0.0005818
564 OSSIFICATION 9 251 7.027e-05 0.0005818
565 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 5 62 7.347e-05 0.0006029
566 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 6 100 7.341e-05 0.0006029
567 LIMBIC SYSTEM DEVELOPMENT 6 100 7.341e-05 0.0006029
568 RESPONSE TO ESTRADIOL 7 146 7.647e-05 0.0006264
569 NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 6 102 8.198e-05 0.0006704
570 INFLAMMATORY RESPONSE 12 454 8.573e-05 0.0006998
571 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 34 9.061e-05 0.0007304
572 FOREBRAIN NEURON DEVELOPMENT 4 34 9.061e-05 0.0007304
573 NEURONAL STEM CELL DIVISION 3 13 9.121e-05 0.0007304
574 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 4 34 9.061e-05 0.0007304
575 RESPONSE TO FLUID SHEAR STRESS 4 34 9.061e-05 0.0007304
576 T CELL HOMEOSTASIS 4 34 9.061e-05 0.0007304
577 ORGAN FORMATION 4 34 9.061e-05 0.0007304
578 REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 3 13 9.121e-05 0.0007304
579 EYELID DEVELOPMENT IN CAMERA TYPE EYE 3 13 9.121e-05 0.0007304
580 INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY 3 13 9.121e-05 0.0007304
581 NEUROBLAST DIVISION 3 13 9.121e-05 0.0007304
582 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 15 684 9.193e-05 0.000735
583 CALCIUM ION IMPORT 5 65 9.222e-05 0.000736
584 SINGLE ORGANISM CELL ADHESION 12 459 9.506e-05 0.0007574
585 CEREBRAL CORTEX DEVELOPMENT 6 105 9.632e-05 0.0007657
586 ACTIVATION OF INNATE IMMUNE RESPONSE 8 204 9.655e-05 0.0007657
587 MULTICELLULAR ORGANISM REPRODUCTION 16 768 9.66e-05 0.0007657
588 NEGATIVE REGULATION OF CELL DIFFERENTIATION 14 609 9.733e-05 0.0007702
589 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 5 66 9.922e-05 0.0007812
590 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 5 66 9.922e-05 0.0007812
591 POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 5 66 9.922e-05 0.0007812
592 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 6 106 0.0001015 0.0007979
593 ACTIVATION OF JUN KINASE ACTIVITY 4 35 0.0001017 0.0007983
594 REGULATION OF LEUKOCYTE PROLIFERATION 8 206 0.0001033 0.0008079
595 CELL PROJECTION ASSEMBLY 9 264 0.0001033 0.0008079
596 CELL CYCLE ARREST 7 154 0.0001069 0.000832
597 PLATELET DEGRANULATION 6 107 0.0001069 0.000832
598 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 5 67 0.0001066 0.000832
599 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 6 108 0.0001126 0.0008745
600 POSITIVE CHEMOTAXIS 4 36 0.0001138 0.0008828
601 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 5 68 0.0001144 0.0008861
602 BONE DEVELOPMENT 7 156 0.0001158 0.0008924
603 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 3 14 0.0001155 0.0008924
604 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 7 156 0.0001158 0.0008924
605 RESPONSE TO HYDROGEN PEROXIDE 6 109 0.0001185 0.000911
606 RESPONSE TO PURINE CONTAINING COMPOUND 7 158 0.0001254 0.0009629
607 MULTI MULTICELLULAR ORGANISM PROCESS 8 213 0.0001302 0.0009978
608 I KAPPAB KINASE NF KAPPAB SIGNALING 5 70 0.0001314 0.001004
609 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 5 70 0.0001314 0.001004
610 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 24 1517 0.0001334 0.001017
611 ESTABLISHMENT OF PROTEIN LOCALIZATION 23 1423 0.000137 0.001043
612 RESPONSE TO AMINO ACID 6 112 0.0001376 0.001046
613 REGULATION OF HORMONE LEVELS 12 478 0.000139 0.001055
614 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 4 38 0.0001411 0.001066
615 REGULATION OF DNA REPLICATION 7 161 0.000141 0.001066
616 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 4 38 0.0001411 0.001066
617 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 3 15 0.0001436 0.001081
618 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 8 216 0.0001433 0.001081
619 REGULATION OF DNA METABOLIC PROCESS 10 340 0.0001438 0.001081
620 REGULATION OF STEM CELL DIFFERENTIATION 6 113 0.0001445 0.001084
621 MUSCLE ORGAN DEVELOPMENT 9 277 0.0001485 0.001112
622 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 4 39 0.0001564 0.001168
623 EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 4 39 0.0001564 0.001168
624 EMBRYONIC ORGAN MORPHOGENESIS 9 279 0.0001567 0.001168
625 RESPONSE TO INTERLEUKIN 1 6 115 0.0001591 0.001184
626 ASSOCIATIVE LEARNING 5 73 0.0001604 0.001192
627 MUSCLE SYSTEM PROCESS 9 282 0.0001697 0.00126
628 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 4 40 0.0001728 0.001279
629 REGULATION OF FILOPODIUM ASSEMBLY 4 40 0.0001728 0.001279
630 ALCOHOL METABOLIC PROCESS 10 348 0.0001736 0.001282
631 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 3 16 0.0001759 0.001289
632 CARDIAC MYOFIBRIL ASSEMBLY 3 16 0.0001759 0.001289
633 NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT 3 16 0.0001759 0.001289
634 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 16 0.0001759 0.001289
635 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 3 16 0.0001759 0.001289
636 CELLULAR GLUCOSE HOMEOSTASIS 5 75 0.0001822 0.001333
637 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 4 41 0.0001905 0.001389
638 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 4 41 0.0001905 0.001389
639 EPITHELIAL CELL DIFFERENTIATION 12 495 0.000192 0.001398
640 NEGATIVE REGULATION OF IMMUNE RESPONSE 6 121 0.0002099 0.001526
641 BRANCH ELONGATION OF AN EPITHELIUM 3 17 0.0002124 0.00154
642 NEGATIVE REGULATION OF PLATELET ACTIVATION 3 17 0.0002124 0.00154
643 REGULATION OF ADAPTIVE IMMUNE RESPONSE 6 123 0.0002295 0.001657
644 REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING 4 43 0.0002296 0.001657
645 T CELL DIFFERENTIATION 6 123 0.0002295 0.001657
646 INORGANIC ION TRANSMEMBRANE TRANSPORT 13 583 0.0002344 0.001688
647 GLIOGENESIS 7 175 0.0002355 0.001694
648 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 8 233 0.0002402 0.00172
649 RESPONSE TO TUMOR NECROSIS FACTOR 8 233 0.0002402 0.00172
650 NEGATIVE REGULATION OF CELL CYCLE 11 433 0.0002398 0.00172
651 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 11 437 0.0002594 0.001854
652 CIRCULATORY SYSTEM PROCESS 10 366 0.0002601 0.001856
653 REGULATION OF WOUND HEALING 6 126 0.0002615 0.001861
654 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 5 81 0.0002616 0.001861
655 EMBRYONIC PLACENTA DEVELOPMENT 5 83 0.0002931 0.002082
656 REGULATION OF REPRODUCTIVE PROCESS 6 129 0.0002969 0.002099
657 NUCLEAR IMPORT 6 129 0.0002969 0.002099
658 EXTRACELLULAR STRUCTURE ORGANIZATION 9 304 0.0002961 0.002099
659 REGULATION OF ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLE PROPIONATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY 3 19 0.0002996 0.002103
660 KIDNEY VASCULATURE DEVELOPMENT 3 19 0.0002996 0.002103
661 NEGATIVE REGULATION OF MEIOTIC CELL CYCLE 3 19 0.0002996 0.002103
662 PLATELET MORPHOGENESIS 3 19 0.0002996 0.002103
663 RENAL SYSTEM VASCULATURE DEVELOPMENT 3 19 0.0002996 0.002103
664 POSITIVE REGULATION OF OSSIFICATION 5 84 0.0003099 0.002172
665 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 6 131 0.0003225 0.002256
666 PALATE DEVELOPMENT 5 85 0.0003275 0.002288
667 CELL CYCLE 21 1316 0.0003286 0.002292
668 EPITHELIAL CELL DEVELOPMENT 7 186 0.0003411 0.002376
669 REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS 5 86 0.0003458 0.002405
670 POSITIVE REGULATION OF CELL ACTIVATION 9 311 0.0003497 0.002421
671 TRACHEA DEVELOPMENT 3 20 0.0003507 0.002421
672 PROTEIN REFOLDING 3 20 0.0003507 0.002421
673 HEMOSTASIS 9 311 0.0003497 0.002421
674 MYELOID DENDRITIC CELL DIFFERENTIATION 3 20 0.0003507 0.002421
675 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 4 48 0.0003524 0.002429
676 TISSUE REMODELING 5 87 0.0003648 0.002511
677 GLOMERULUS DEVELOPMENT 4 49 0.0003816 0.002619
678 CELLULAR RESPONSE TO CALCIUM ION 4 49 0.0003816 0.002619
679 CELLULAR RESPONSE TO INTERLEUKIN 1 5 88 0.0003846 0.002636
680 GLIAL CELL DIFFERENTIATION 6 136 0.0003941 0.002697
681 EPITHELIAL CELL PROLIFERATION 5 89 0.0004052 0.002769
682 B CELL HOMEOSTASIS 3 21 0.0004071 0.002777
683 SKELETAL MUSCLE ORGAN DEVELOPMENT 6 137 0.0004098 0.002792
684 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 4 50 0.0004126 0.002794
685 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 4 50 0.0004126 0.002794
686 RESPONSE TO PROGESTERONE 4 50 0.0004126 0.002794
687 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 4 50 0.0004126 0.002794
688 MIDBRAIN DEVELOPMENT 5 90 0.0004267 0.002886
689 LEUKOCYTE CELL CELL ADHESION 8 255 0.0004395 0.002968
690 ARTERY MORPHOGENESIS 4 51 0.0004453 0.003003
691 REGULATION OF PEPTIDASE ACTIVITY 10 392 0.0004469 0.003009
692 EAR DEVELOPMENT 7 195 0.0004532 0.003048
693 CATION TRANSPORT 15 796 0.0004693 0.003137
694 CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION 3 22 0.000469 0.003137
695 POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION 3 22 0.000469 0.003137
696 SYNAPTIC TRANSMISSION GLUTAMATERGIC 3 22 0.000469 0.003137
697 REGULATION OF PROTEOLYSIS 14 711 0.000474 0.003164
698 NEGATIVE REGULATION OF T CELL PROLIFERATION 4 52 0.0004798 0.003194
699 POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 4 52 0.0004798 0.003194
700 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 6 143 0.0005146 0.003421
701 CELLULAR RESPONSE TO AMINO ACID STIMULUS 4 53 0.0005162 0.003421
702 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 4 53 0.0005162 0.003421
703 REGULATION OF DNA BIOSYNTHETIC PROCESS 5 94 0.0005212 0.003449
704 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 8 262 0.0005256 0.003474
705 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 3 23 0.0005365 0.003536
706 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 3 23 0.0005365 0.003536
707 CELLULAR RESPONSE TO ABIOTIC STIMULUS 8 263 0.0005389 0.003547
708 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 5 95 0.000547 0.003595
709 CELLULAR RESPONSE TO EXTERNAL STIMULUS 8 264 0.0005525 0.003626
710 TRANSMISSION OF NERVE IMPULSE 4 54 0.0005545 0.003634
711 CARDIOCYTE DIFFERENTIATION 5 96 0.0005739 0.003756
712 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 11 482 0.0005912 0.003863
713 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 4 55 0.0005947 0.003874
714 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 4 55 0.0005947 0.003874
715 REGULATION OF T CELL PROLIFERATION 6 147 0.0005953 0.003874
716 RESPONSE TO STEROL 3 24 0.0006101 0.003959
717 POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION 3 24 0.0006101 0.003959
718 MEMORY 5 98 0.0006305 0.004075
719 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 5 98 0.0006305 0.004075
720 MYELOID LEUKOCYTE ACTIVATION 5 98 0.0006305 0.004075
721 SMAD PROTEIN SIGNAL TRANSDUCTION 4 56 0.000637 0.0041
722 EPITHELIAL TO MESENCHYMAL TRANSITION 4 56 0.000637 0.0041
723 NEURON NEURON SYNAPTIC TRANSMISSION 4 56 0.000637 0.0041
724 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 7 207 0.0006465 0.004155
725 STRIATED MUSCLE CONTRACTION 5 99 0.0006604 0.004227
726 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 5 99 0.0006604 0.004227
727 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 5 99 0.0006604 0.004227
728 MYOTUBE DIFFERENTIATION 4 57 0.0006814 0.004355
729 EPITHELIAL CELL APOPTOTIC PROCESS 3 25 0.0006897 0.004394
730 REGULATION OF GLUCOSE TRANSPORT 5 100 0.0006913 0.004394
731 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 5 100 0.0006913 0.004394
732 THYROID GLAND DEVELOPMENT 3 25 0.0006897 0.004394
733 LYMPHOCYTE ACTIVATION 9 342 0.000693 0.004399
734 DIVALENT INORGANIC CATION HOMEOSTASIS 9 343 0.0007076 0.004485
735 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 5 101 0.0007233 0.004579
736 NEGATIVE REGULATION OF WOUND HEALING 4 58 0.0007279 0.004602
737 HEART MORPHOGENESIS 7 212 0.0007442 0.004698
738 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 5 102 0.0007563 0.004762
739 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 5 102 0.0007563 0.004762
740 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 4 59 0.0007767 0.004857
741 VASCULOGENESIS 4 59 0.0007767 0.004857
742 REGULATION OF P38MAPK CASCADE 3 26 0.0007757 0.004857
743 MYELOID DENDRITIC CELL ACTIVATION 3 26 0.0007757 0.004857
744 REGULATION OF CELL FATE COMMITMENT 3 26 0.0007757 0.004857
745 PROTEIN IMPORT 6 155 0.000786 0.004902
746 GASTRULATION 6 155 0.000786 0.004902
747 PROTEIN LOCALIZATION TO NUCLEUS 6 156 0.0008128 0.005063
748 REGULATION OF IMMUNE EFFECTOR PROCESS 10 424 0.0008184 0.005091
749 REGULATION OF GLUCOSE IMPORT 4 60 0.0008277 0.005128
750 STEM CELL PROLIFERATION 4 60 0.0008277 0.005128
751 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 4 60 0.0008277 0.005128
752 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 7 216 0.0008304 0.005138
753 ODONTOGENESIS 5 105 0.0008623 0.005328
754 EXCITATORY POSTSYNAPTIC POTENTIAL 3 27 0.0008682 0.005329
755 POSITIVE REGULATION OF FILOPODIUM ASSEMBLY 3 27 0.0008682 0.005329
756 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 27 0.0008682 0.005329
757 RESPONSE TO LITHIUM ION 3 27 0.0008682 0.005329
758 AXIS ELONGATION 3 27 0.0008682 0.005329
759 REGULATION OF BODY FLUID LEVELS 11 506 0.0008802 0.005394
760 POSITIVE REGULATION OF CYCLASE ACTIVITY 4 61 0.000881 0.005394
761 REGULATION OF FAT CELL DIFFERENTIATION 5 106 0.0008999 0.005502
762 FOREBRAIN CELL MIGRATION 4 62 0.0009367 0.00572
763 REGULATION OF PROTEIN STABILITY 7 221 0.0009492 0.005788
764 NEGATIVE REGULATION OF DENDRITE DEVELOPMENT 3 28 0.0009674 0.005892
765 POSITIVE REGULATION OF RESPONSE TO WOUNDING 6 162 0.0009888 0.006014
766 REGULATION OF OSTEOCLAST DIFFERENTIATION 4 63 0.0009948 0.006035
767 REGULATION OF CARTILAGE DEVELOPMENT 4 63 0.0009948 0.006035
768 NEGATIVE REGULATION OF CELL ADHESION 7 223 0.001 0.00606
769 ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE 9 361 0.001014 0.006137
770 REGULATION OF NUCLEAR DIVISION 6 163 0.001021 0.006168
771 FORMATION OF PRIMARY GERM LAYER 5 110 0.001063 0.006415
772 REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 3 29 0.001074 0.006429
773 POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 3 29 0.001074 0.006429
774 REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 3 29 0.001074 0.006429
775 REGULATION OF HEART MORPHOGENESIS 3 29 0.001074 0.006429
776 NEUROBLAST PROLIFERATION 3 29 0.001074 0.006429
777 POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 3 29 0.001074 0.006429
778 ALCOHOL BIOSYNTHETIC PROCESS 5 111 0.001107 0.00662
779 CELL FATE COMMITMENT 7 227 0.001109 0.006623
780 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 6 166 0.001121 0.00669
781 ZYMOGEN ACTIVATION 5 112 0.001152 0.006864
782 INTRACELLULAR PROTEIN TRANSPORT 14 781 0.001177 0.006997
783 SMOOTH MUSCLE CELL DIFFERENTIATION 3 30 0.001187 0.006997
784 FOREBRAIN GENERATION OF NEURONS 4 66 0.001184 0.006997
785 CELL CELL ADHESION 12 608 0.001188 0.006997
786 ESTABLISHMENT OF ENDOTHELIAL BARRIER 3 30 0.001187 0.006997
787 MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 3 30 0.001187 0.006997
788 REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY 3 30 0.001187 0.006997
789 OSTEOCLAST DIFFERENTIATION 3 30 0.001187 0.006997
790 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 3 30 0.001187 0.006997
791 REGULATION OF SYNAPSE ORGANIZATION 5 113 0.001199 0.007052
792 POSITIVE REGULATION OF ENDOCYTOSIS 5 114 0.001247 0.007316
793 REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 5 114 0.001247 0.007316
794 ION TRANSPORT 19 1262 0.00129 0.007548
795 MUSCLE CONTRACTION 7 233 0.001289 0.007548
796 ADULT WALKING BEHAVIOR 3 31 0.001307 0.007613
797 TISSUE HOMEOSTASIS 6 171 0.001306 0.007613
798 WALKING BEHAVIOR 3 31 0.001307 0.007613
799 REGULATION OF SYNAPTIC VESICLE TRANSPORT 3 31 0.001307 0.007613
800 REGULATION OF CELL JUNCTION ASSEMBLY 4 68 0.001324 0.007681
801 MULTICELLULAR ORGANISMAL RESPONSE TO STRESS 4 68 0.001324 0.007681
802 ORGAN GROWTH 4 68 0.001324 0.007681
803 NEGATIVE REGULATION OF CELL DEVELOPMENT 8 303 0.001344 0.007791
804 FEMALE SEX DIFFERENTIATION 5 116 0.001347 0.007797
805 REGULATION OF CELL SUBSTRATE ADHESION 6 173 0.001386 0.008012
806 NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION 4 69 0.001398 0.00804
807 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 5 117 0.0014 0.00804
808 POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 4 69 0.001398 0.00804
809 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 5 117 0.0014 0.00804
810 NEGATIVE REGULATION OF OSSIFICATION 4 69 0.001398 0.00804
811 PATTERNING OF BLOOD VESSELS 3 32 0.001435 0.008213
812 METANEPHRIC NEPHRON DEVELOPMENT 3 32 0.001435 0.008213
813 REGULATION OF ACTIN CYTOSKELETON REORGANIZATION 3 32 0.001435 0.008213
814 CELLULAR RESPONSE TO LIPID 10 457 0.001437 0.008214
815 NEGATIVE REGULATION OF TRANSPORT 10 458 0.00146 0.008338
816 MULTI ORGANISM REPRODUCTIVE PROCESS 15 891 0.001467 0.008367
817 ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS 6 175 0.00147 0.008371
818 REGULATION OF MEMBRANE PERMEABILITY 4 70 0.001475 0.008388
819 CELL CYCLE PROCESS 17 1081 0.001481 0.008414
820 ENDODERM DEVELOPMENT 4 71 0.001554 0.008819
821 DENDRITIC CELL DIFFERENTIATION 3 33 0.001571 0.008869
822 CELLULAR SENESCENCE 3 33 0.001571 0.008869
823 NEGATIVE REGULATION OF JNK CASCADE 3 33 0.001571 0.008869
824 REGULATION OF DENDRITE DEVELOPMENT 5 120 0.001566 0.008869
825 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 5 121 0.001624 0.009148
826 REGULATION OF B CELL ACTIVATION 5 121 0.001624 0.009148
827 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 10 465 0.001634 0.009191
828 POSITIVE REGULATION OF CELL CELL ADHESION 7 243 0.001639 0.009212
829 REGULATION OF MITOTIC CELL CYCLE 10 468 0.001713 0.009613
830 POSITIVE REGULATION OF PROTEIN BINDING 4 73 0.001722 0.009656
831 POSITIVE REGULATION OF MITOTIC CELL CYCLE 5 123 0.001746 0.009751
832 ENDOCRINE SYSTEM DEVELOPMENT 5 123 0.001746 0.009751
833 LOCOMOTORY BEHAVIOR 6 181 0.001744 0.009751
834 CELLULAR RESPONSE TO HORMONE STIMULUS 11 552 0.001763 0.009835
835 RESPONSE TO KETONE 6 182 0.001793 0.009993
NumGOOverlapSizeP ValueAdj. P Value
1 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 25 92 2.109e-33 1.96e-30
2 PROTEIN KINASE ACTIVITY 45 640 7.571e-33 3.517e-30
3 KINASE ACTIVITY 48 842 5.576e-31 1.727e-28
4 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 48 992 8.863e-28 2.059e-25
5 RECEPTOR SIGNALING PROTEIN ACTIVITY 26 172 1.611e-27 2.993e-25
6 PROTEIN SERINE THREONINE KINASE ACTIVITY 35 445 5.406e-27 8.37e-25
7 RIBONUCLEOTIDE BINDING 53 1860 4.886e-20 6.484e-18
8 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 21 228 8.853e-18 1.028e-15
9 MOLECULAR FUNCTION REGULATOR 42 1353 6.229e-17 6.43e-15
10 ENZYME BINDING 47 1737 1.068e-16 9.02e-15
11 ADENYL NUCLEOTIDE BINDING 44 1514 1.041e-16 9.02e-15
12 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 22 303 2.226e-16 1.723e-14
13 GROWTH FACTOR ACTIVITY 17 160 1.27e-15 9.074e-14
14 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 13 70 1.855e-15 1.231e-13
15 VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 11 42 4.719e-15 2.923e-13
16 KINASE BINDING 27 606 1.267e-14 7.357e-13
17 MAP KINASE KINASE KINASE ACTIVITY 9 22 1.432e-14 7.826e-13
18 HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 7 11 2.282e-13 1.178e-11
19 SIGNAL TRANSDUCER ACTIVITY 42 1731 3.181e-13 1.555e-11
20 RECEPTOR BINDING 38 1476 9.955e-13 4.624e-11
21 PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 15 178 1.997e-12 8.835e-11
22 MAP KINASE PHOSPHATASE ACTIVITY 7 14 2.332e-12 9.848e-11
23 GROWTH FACTOR RECEPTOR BINDING 13 129 6.486e-12 2.62e-10
24 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 8 28 1.301e-11 5.036e-10
25 GROWTH FACTOR BINDING 12 123 6.367e-11 2.366e-09
26 CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 12 128 1.02e-10 3.643e-09
27 MAP KINASE ACTIVITY 6 14 3.029e-10 1.042e-08
28 PROTEIN TYROSINE KINASE ACTIVITY 13 176 3.305e-10 1.097e-08
29 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 8 43 5.558e-10 1.78e-08
30 PHOSPHATASE ACTIVITY 15 275 9.546e-10 2.956e-08
31 PHOSPHOLIPASE A2 ACTIVITY 7 31 1.618e-09 4.849e-08
32 DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 12 167 2.234e-09 6.487e-08
33 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 8 51 2.328e-09 6.555e-08
34 VOLTAGE GATED CATION CHANNEL ACTIVITY 11 134 2.625e-09 7.172e-08
35 PROTEIN TYROSINE PHOSPHATASE ACTIVITY 10 103 2.77e-09 7.351e-08
36 PROTEIN DIMERIZATION ACTIVITY 28 1149 5.868e-09 1.514e-07
37 DIACYLGLYCEROL BINDING 5 11 6.987e-09 1.754e-07
38 VOLTAGE GATED ION CHANNEL ACTIVITY 12 190 9.639e-09 2.296e-07
39 HYDROLASE ACTIVITY ACTING ON ESTER BONDS 22 739 9.461e-09 2.296e-07
40 MAGNESIUM ION BINDING 12 199 1.619e-08 3.759e-07
41 PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY 7 45 2.574e-08 5.832e-07
42 MACROMOLECULAR COMPLEX BINDING 30 1399 2.816e-08 6.229e-07
43 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 5 15 4.44e-08 9.593e-07
44 PHOSPHORIC ESTER HYDROLASE ACTIVITY 15 368 4.805e-08 1.015e-06
45 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 8 81 9.861e-08 2.036e-06
46 MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING 5 18 1.246e-07 2.516e-06
47 HEPARIN BINDING 10 157 1.595e-07 3.154e-06
48 GLYCOSAMINOGLYCAN BINDING 11 205 2.147e-07 4.155e-06
49 PROTEIN COMPLEX BINDING 22 935 5.708e-07 1.082e-05
50 PLATELET DERIVED GROWTH FACTOR BINDING 4 11 7.306e-07 1.357e-05
51 IDENTICAL PROTEIN BINDING 25 1209 9.651e-07 1.758e-05
52 PROTEIN HETERODIMERIZATION ACTIVITY 15 468 1.041e-06 1.859e-05
53 ENZYME ACTIVATOR ACTIVITY 15 471 1.127e-06 1.975e-05
54 CATION CHANNEL ACTIVITY 12 298 1.281e-06 2.204e-05
55 GATED CHANNEL ACTIVITY 12 325 3.149e-06 5.319e-05
56 CYTOKINE RECEPTOR BINDING 11 271 3.345e-06 5.549e-05
57 PHOSPHOLIPASE ACTIVITY 7 94 4.365e-06 7.115e-05
58 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 6 64 5.674e-06 9.088e-05
59 SULFUR COMPOUND BINDING 10 234 6.032e-06 9.498e-05
60 PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY 5 39 7.438e-06 0.0001152
61 CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 5 42 1.081e-05 0.0001646
62 ENZYME REGULATOR ACTIVITY 20 959 1.191e-05 0.0001785
63 LIPASE ACTIVITY 7 117 1.851e-05 0.0002729
64 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 5 50 2.573e-05 0.0003735
65 CALCIUM ION BINDING 16 697 3.07e-05 0.0004388
66 CHEMOATTRACTANT ACTIVITY 4 27 3.562e-05 0.0005013
67 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 12 417 3.8e-05 0.0005246
68 CHANNEL REGULATOR ACTIVITY 7 131 3.84e-05 0.0005246
69 PROTEIN HOMODIMERIZATION ACTIVITY 16 722 4.679e-05 0.000621
70 CARBOXYLIC ESTER HYDROLASE ACTIVITY 7 135 4.654e-05 0.000621
71 MAP KINASE KINASE ACTIVITY 3 12 7.052e-05 0.0009227
72 KINASE ACTIVATOR ACTIVITY 5 62 7.347e-05 0.000948
73 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 12 464 0.0001053 0.00134
74 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC 3 14 0.0001155 0.00145
75 SMAD BINDING 5 72 0.0001502 0.001861
76 MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING 3 16 0.0001759 0.002122
77 TRANSFORMING GROWTH FACTOR BETA BINDING 3 16 0.0001759 0.002122
78 GTP DEPENDENT PROTEIN BINDING 3 17 0.0002124 0.00253
79 CALMODULIN BINDING 7 179 0.0002703 0.003179
80 PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY 3 19 0.0002996 0.003437
81 HISTONE KINASE ACTIVITY 3 19 0.0002996 0.003437
82 TRANSCRIPTION FACTOR BINDING 12 524 0.0003225 0.003635
83 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING 4 47 0.0003248 0.003635
84 KINASE REGULATOR ACTIVITY 7 186 0.0003411 0.003728
85 INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 12 527 0.0003396 0.003728
86 GTPASE ACTIVITY 8 246 0.000346 0.003738
87 GUANYL NUCLEOTIDE BINDING 10 390 0.0004294 0.004585
88 CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 3 23 0.0005365 0.005664
89 GLYCOPROTEIN BINDING 5 101 0.0007233 0.007549
90 HISTONE DEACETYLASE BINDING 5 105 0.0008623 0.0089
NumGOOverlapSizeP ValueAdj. P Value
1 VOLTAGE GATED CALCIUM CHANNEL COMPLEX 13 40 5.616e-19 3.28e-16
2 CALCIUM CHANNEL COMPLEX 13 62 3.404e-16 9.94e-14
3 PLASMA MEMBRANE PROTEIN COMPLEX 23 510 1.132e-12 2.203e-10
4 CATION CHANNEL COMPLEX 13 167 1.719e-10 2.509e-08
5 SIDE OF MEMBRANE 17 428 8.456e-09 9.877e-07
6 SARCOLEMMA 10 125 1.828e-08 1.779e-06
7 CYTOPLASMIC SIDE OF MEMBRANE 11 170 3.182e-08 2.655e-06
8 MEMBRANE PROTEIN COMPLEX 25 1020 3.922e-08 2.863e-06
9 PERINUCLEAR REGION OF CYTOPLASM 19 642 1.175e-07 7.624e-06
10 SOMATODENDRITIC COMPARTMENT 19 650 1.423e-07 8.31e-06
11 NEURON PROJECTION 23 942 1.586e-07 8.421e-06
12 NEURON PART 27 1265 1.747e-07 8.504e-06
13 CELL BODY 16 494 3.862e-07 1.735e-05
14 TRANSPORTER COMPLEX 13 321 4.252e-07 1.774e-05
15 T TUBULE 6 45 6.874e-07 2.676e-05
16 SYNAPSE 18 754 5.534e-06 0.000202
17 VESICLE LUMEN 7 106 9.693e-06 0.000333
18 CELL SUBSTRATE JUNCTION 12 398 2.412e-05 0.0007826
19 EXTRACELLULAR SPACE 24 1376 2.885e-05 0.0008866
20 PROTEIN KINASE COMPLEX 6 90 4.06e-05 0.001043
21 PLATELET ALPHA GRANULE LUMEN 5 55 4.108e-05 0.001043
22 MEMBRANE MICRODOMAIN 10 288 3.627e-05 0.001043
23 CELL PROJECTION 28 1786 3.912e-05 0.001043
24 EXCITATORY SYNAPSE 8 197 7.569e-05 0.001842
25 INTRINSIC COMPONENT OF THE CYTOPLASMIC SIDE OF THE PLASMA MEMBRANE 3 15 0.0001436 0.003355
26 PLATELET ALPHA GRANULE 5 75 0.0001822 0.0038
27 INTRACELLULAR VESICLE 21 1259 0.0001804 0.0038
28 ANCHORING JUNCTION 12 489 0.0001716 0.0038
29 I BAND 6 121 0.0002099 0.004228
30 CELL SURFACE 15 757 0.0002767 0.005386
31 SECRETORY GRANULE LUMEN 5 85 0.0003275 0.006169
32 DENDRITE 11 451 0.0003391 0.006189
33 SYNAPSE PART 13 610 0.0003618 0.006403
34 CELL JUNCTION 19 1151 0.0004284 0.007358
35 RECEPTOR COMPLEX 9 327 0.000503 0.008392

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04010_MAPK_signaling_pathway 140 268 2.779e-282 5.002e-280
2 hsa04014_Ras_signaling_pathway 56 236 2.533e-72 2.279e-70
3 hsa04912_GnRH_signaling_pathway 27 101 7.982e-36 4.789e-34
4 hsa04722_Neurotrophin_signaling_pathway 28 127 1.599e-34 7.197e-33
5 hsa04810_Regulation_of_actin_cytoskeleton 31 214 3.635e-32 1.309e-30
6 hsa04370_VEGF_signaling_pathway 23 76 5.181e-32 1.554e-30
7 hsa04664_Fc_epsilon_RI_signaling_pathway 23 79 1.453e-31 3.737e-30
8 hsa04151_PI3K_AKT_signaling_pathway 32 351 1.117e-26 2.513e-25
9 hsa04660_T_cell_receptor_signaling_pathway 21 108 8.71e-25 1.742e-23
10 hsa04720_Long.term_potentiation 18 70 8.988e-24 1.618e-22
11 hsa04380_Osteoclast_differentiation 21 128 3.886e-23 6.359e-22
12 hsa04510_Focal_adhesion 23 200 1.312e-21 1.968e-20
13 hsa04662_B_cell_receptor_signaling_pathway 17 75 1.801e-21 2.494e-20
14 hsa04650_Natural_killer_cell_mediated_cytotoxicity 19 136 1.233e-19 1.585e-18
15 hsa04012_ErbB_signaling_pathway 16 87 1.072e-18 1.286e-17
16 hsa04730_Long.term_depression 15 70 1.145e-18 1.288e-17
17 hsa04914_Progesterone.mediated_oocyte_maturation 14 87 1.223e-15 1.295e-14
18 hsa04540_Gap_junction 14 90 2.008e-15 2.008e-14
19 hsa04270_Vascular_smooth_muscle_contraction 15 116 3.332e-15 3.156e-14
20 hsa04020_Calcium_signaling_pathway 17 177 6.982e-15 6.283e-14
21 hsa04620_Toll.like_receptor_signaling_pathway 14 102 1.23e-14 1.055e-13
22 hsa04062_Chemokine_signaling_pathway 17 189 2.091e-14 1.711e-13
23 hsa04310_Wnt_signaling_pathway 15 151 1.775e-13 1.389e-12
24 hsa04210_Apoptosis 12 89 1.286e-12 9.642e-12
25 hsa00592_alpha.Linolenic_acid_metabolism 7 20 5.087e-11 3.662e-10
26 hsa04972_Pancreatic_secretion 11 101 1.235e-10 8.547e-10
27 hsa04144_Endocytosis 14 203 1.666e-10 1.111e-09
28 hsa04910_Insulin_signaling_pathway 12 138 2.465e-10 1.585e-09
29 hsa00591_Linoleic_acid_metabolism 7 30 1.26e-09 7.822e-09
30 hsa04360_Axon_guidance 11 130 1.9e-09 1.14e-08
31 hsa00565_Ether_lipid_metabolism 7 36 4.99e-09 2.897e-08
32 hsa04114_Oocyte_meiosis 10 114 7.486e-09 4.211e-08
33 hsa04621_NOD.like_receptor_signaling_pathway 8 59 7.736e-09 4.22e-08
34 hsa04975_Fat_digestion_and_absorption 7 46 3.018e-08 1.598e-07
35 hsa04622_RIG.I.like_receptor_signaling_pathway 8 71 3.459e-08 1.779e-07
36 hsa00590_Arachidonic_acid_metabolism 7 59 1.783e-07 8.917e-07
37 hsa04666_Fc_gamma_R.mediated_phagocytosis 8 95 3.432e-07 1.67e-06
38 hsa04320_Dorso.ventral_axis_formation 5 25 7.426e-07 3.517e-06
39 hsa04520_Adherens_junction 7 73 7.851e-07 3.624e-06
40 hsa04260_Cardiac_muscle_contraction 7 77 1.132e-06 5.094e-06
41 hsa00564_Glycerophospholipid_metabolism 7 80 1.47e-06 6.452e-06
42 hsa04150_mTOR_signaling_pathway 6 52 1.651e-06 7.074e-06
43 hsa04350_TGF.beta_signaling_pathway 7 85 2.218e-06 9.285e-06
44 hsa04530_Tight_junction 8 133 4.427e-06 1.811e-05
45 hsa04920_Adipocytokine_signaling_pathway 6 68 8.095e-06 3.238e-05
46 hsa04390_Hippo_signaling_pathway 8 154 1.303e-05 5.099e-05
47 hsa04670_Leukocyte_transendothelial_migration 7 117 1.851e-05 7.088e-05
48 hsa04916_Melanogenesis 6 101 7.76e-05 0.000291
49 hsa04141_Protein_processing_in_endoplasmic_reticulum 7 168 0.0001834 0.0006736
50 hsa04110_Cell_cycle 5 128 0.002079 0.007484
51 hsa04612_Antigen_processing_and_presentation 4 78 0.002197 0.007755
52 hsa04960_Aldosterone.regulated_sodium_reabsorption 3 42 0.003156 0.01093
53 hsa04973_Carbohydrate_digestion_and_absorption 3 44 0.003605 0.01224
54 hsa04742_Taste_transduction 3 52 0.005775 0.01925
55 hsa04115_p53_signaling_pathway 3 69 0.01256 0.04112
56 hsa04971_Gastric_acid_secretion 3 74 0.01516 0.04872
57 hsa04630_Jak.STAT_signaling_pathway 4 155 0.02364 0.07423
58 hsa04640_Hematopoietic_cell_lineage 3 88 0.02392 0.07423
59 hsa04970_Salivary_secretion 3 89 0.02463 0.07514
60 hsa03040_Spliceosome 3 128 0.06098 0.1829
61 hsa04070_Phosphatidylinositol_signaling_system 2 78 0.1037 0.3059

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-429;hsa-miR-577;hsa-miR-93-5p 11 MAP3K12 Sponge network 0.433 0.33816 0.29 0.54449 0.619
2

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-301a-3p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-324-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-93-5p 19 MAP3K12 Sponge network 0.551 0.56177 0.29 0.54449 0.597
3

CECR7

 hsa-miR-141-5p;hsa-miR-148a-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-24-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-491-5p;hsa-miR-502-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 24 PRKCB Sponge network 0.551 0.56177 -0.289 0.6299 0.583
4

CECR7

 hsa-let-7g-5p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29a-5p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-582-5p;hsa-miR-652-3p;hsa-miR-7-1-3p 21 MRAS Sponge network 0.551 0.56177 0.229 0.7586 0.582
5

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-192-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-374a-3p;hsa-miR-421;hsa-miR-424-5p;hsa-miR-484;hsa-miR-577;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 23 FGF7 Sponge network 1.057 0.31716 0.117 0.8481 0.575
6

EMX2OS

 hsa-let-7g-5p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29a-5p;hsa-miR-29b-3p;hsa-miR-30d-3p;hsa-miR-32-3p;hsa-miR-324-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-424-5p;hsa-miR-7-1-3p 22 MRAS Sponge network 1.057 0.31716 0.229 0.7586 0.574
7

EMX2OS

 hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-222-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-374a-3p;hsa-miR-484;hsa-miR-532-3p;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-625-5p;hsa-miR-629-5p;hsa-miR-7-5p;hsa-miR-760 16 FGF1 Sponge network 1.057 0.31716 0.817 0.03603 0.558
8

CECR7

 hsa-miR-130b-5p;hsa-miR-17-3p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-197-3p;hsa-miR-215-5p;hsa-miR-24-3p;hsa-miR-26b-5p;hsa-miR-335-3p;hsa-miR-361-5p;hsa-miR-491-5p;hsa-miR-590-3p 12 IL1R1 Sponge network 0.551 0.56177 0.097 0.93138 0.556
9

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-324-3p;hsa-miR-454-3p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-93-5p 17 MAP3K12 Sponge network 1.057 0.31716 0.29 0.54449 0.554
10

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7f-2-3p;hsa-let-7g-5p;hsa-miR-10a-3p;hsa-miR-1296-5p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200c-5p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-5p;hsa-miR-32-3p;hsa-miR-324-3p;hsa-miR-331-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-33b-5p;hsa-miR-362-3p;hsa-miR-425-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-760 35 MEF2C Sponge network 0.551 0.56177 0.174 0.82808 0.543
11

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-374b-5p;hsa-miR-421;hsa-miR-424-5p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-502-5p;hsa-miR-505-3p;hsa-miR-577;hsa-miR-663b;hsa-miR-93-5p 25 AKT3 Sponge network 1.057 0.31716 0.457 0.53933 0.542
12

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-192-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 18 FGF7 Sponge network 0.551 0.56177 0.117 0.8481 0.536
13

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-1262;hsa-miR-135b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-424-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-93-5p 18 FGFR1 Sponge network 1.057 0.31716 0.202 0.85898 0.535
14

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-1262;hsa-miR-135b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-361-5p;hsa-miR-532-5p;hsa-miR-590-3p;hsa-miR-93-5p 18 FGFR1 Sponge network 0.551 0.56177 0.202 0.85898 0.531
15

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-200b-3p;hsa-miR-26b-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 15 CACNA2D1 Sponge network 0.551 0.56177 0.211 0.75224 0.525
16

MEG3

 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-192-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-429;hsa-miR-577;hsa-miR-582-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 13 FGF7 Sponge network 0.433 0.33816 0.117 0.8481 0.524
17

EMX2OS

 hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-188-5p;hsa-miR-194-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-221-5p;hsa-miR-30c-1-3p;hsa-miR-331-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-484;hsa-miR-505-3p;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 24 MAP3K3 Sponge network 1.057 0.31716 0.007 0.99454 0.524
18

EMX2OS

 hsa-miR-130b-5p;hsa-miR-17-3p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-197-3p;hsa-miR-215-5p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-590-3p 10 IL1R1 Sponge network 1.057 0.31716 0.097 0.93138 0.517
19

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-1275;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-362-5p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-502-5p;hsa-miR-93-5p 20 AKT3 Sponge network 0.551 0.56177 0.457 0.53933 0.508
20

CECR7

 hsa-miR-130b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-590-5p 13 MAPK10 Sponge network 0.551 0.56177 0.278 0.49976 0.504
21

MEG3

 hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-7-1-3p;hsa-miR-96-5p 15 MRAS Sponge network 0.433 0.33816 0.229 0.7586 0.487
22

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-107;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-200b-3p;hsa-miR-21-3p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 19 CACNA2D1 Sponge network 1.057 0.31716 0.211 0.75224 0.487
23

CECR7

 hsa-miR-1275;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-222-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-532-3p;hsa-miR-550a-5p;hsa-miR-590-5p;hsa-miR-625-5p;hsa-miR-629-5p;hsa-miR-760 16 FGF1 Sponge network 0.551 0.56177 0.817 0.03603 0.477
24

EMX2OS

 hsa-miR-16-5p;hsa-miR-196a-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-5p;hsa-miR-331-3p;hsa-miR-378a-3p;hsa-miR-484;hsa-miR-7-5p;hsa-miR-92a-3p 12 FLNA Sponge network 1.057 0.31716 0.162 0.93898 0.476
25

CECR7

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-590-3p 10 PDGFB Sponge network 0.551 0.56177 0.313 0.74314 0.471
26

CECR7

 hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-188-5p;hsa-miR-194-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-221-5p;hsa-miR-331-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 21 MAP3K3 Sponge network 0.551 0.56177 0.007 0.99454 0.456
27

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-10a-3p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200c-5p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-30d-3p;hsa-miR-32-3p;hsa-miR-324-3p;hsa-miR-331-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-33b-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-425-5p;hsa-miR-452-5p;hsa-miR-550a-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-744-3p;hsa-miR-760;hsa-miR-92a-3p;hsa-miR-940 40 MEF2C Sponge network 1.057 0.31716 0.174 0.82808 0.456
28

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-550a-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 31 PDGFRA Sponge network 0.551 0.56177 -0.146 0.90295 0.453
29

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-577;hsa-miR-93-5p 13 FGFR1 Sponge network 0.433 0.33816 0.202 0.85898 0.452
30

MEG3

 hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-194-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-221-5p;hsa-miR-30c-1-3p;hsa-miR-429;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-93-5p;hsa-miR-96-5p 20 MAP3K3 Sponge network 0.433 0.33816 0.007 0.99454 0.437
31

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-148a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-215-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p 27 FGF2 Sponge network 0.551 0.56177 0.037 0.94566 0.412
32

EMX2OS

 hsa-miR-130b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-30d-3p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-940 12 MAPK10 Sponge network 1.057 0.31716 0.278 0.49976 0.408
33

EMX2OS

 hsa-miR-141-5p;hsa-miR-148a-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-452-3p;hsa-miR-484;hsa-miR-502-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-7-5p 21 PRKCB Sponge network 1.057 0.31716 -0.289 0.6299 0.407
34

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-577;hsa-miR-93-5p 12 AKT3 Sponge network 0.433 0.33816 0.457 0.53933 0.405
35

MIAT

 hsa-miR-10a-3p;hsa-miR-135b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-194-5p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-425-5p;hsa-miR-491-3p;hsa-miR-92a-3p;hsa-miR-96-5p 11 MEF2C Sponge network -0.118 0.86338 0.174 0.82808 0.399
36

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p;hsa-miR-96-5p 21 PDGFRA Sponge network 0.433 0.33816 -0.146 0.90295 0.397
37

CECR7

 hsa-miR-10a-5p;hsa-miR-1275;hsa-miR-148b-5p;hsa-miR-17-3p;hsa-miR-18a-3p;hsa-miR-24-3p;hsa-miR-29a-5p;hsa-miR-335-5p;hsa-miR-361-5p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-505-5p;hsa-miR-582-3p;hsa-miR-589-3p;hsa-miR-7-1-3p;hsa-miR-760 16 MAPT Sponge network 0.551 0.56177 0.906 0.06727 0.39
38

EMX2OS

 hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-1266-5p;hsa-miR-1304-5p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-200c-5p;hsa-miR-20a-5p;hsa-miR-29a-5p;hsa-miR-30d-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-374a-3p;hsa-miR-374b-5p;hsa-miR-421;hsa-miR-424-5p;hsa-miR-425-5p;hsa-miR-550a-3p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-592;hsa-miR-660-5p;hsa-miR-7-1-3p;hsa-miR-7-5p;hsa-miR-93-5p;hsa-miR-942-5p 46 CACNA1E Sponge network 1.057 0.31716 -0.022 0.97264 0.386
39

MEG3

 hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-200b-3p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-576-5p;hsa-miR-7-1-3p;hsa-miR-96-5p 12 CACNA2D1 Sponge network 0.433 0.33816 0.211 0.75224 0.381
40

CECR7

 hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-148a-5p;hsa-miR-151a-5p;hsa-miR-15b-3p;hsa-miR-17-3p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-301a-3p;hsa-miR-30b-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-760 21 NTRK2 Sponge network 0.551 0.56177 0.714 0.34423 0.38
41

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-197-3p;hsa-miR-200b-3p;hsa-miR-29a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-627-5p 14 FGF12 Sponge network 1.057 0.31716 -0.073 0.90082 0.377
42

MIAT

 hsa-miR-106b-5p;hsa-miR-135b-5p;hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-19b-3p;hsa-miR-362-5p;hsa-miR-374a-3p;hsa-miR-425-5p;hsa-miR-491-3p;hsa-miR-96-5p 10 CACNA1E Sponge network -0.118 0.86338 -0.022 0.97264 0.375
43

MEG3

 hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-1266-5p;hsa-miR-1304-5p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-200c-5p;hsa-miR-20a-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-425-5p;hsa-miR-577;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-92a-1-5p;hsa-miR-93-5p;hsa-miR-942-5p;hsa-miR-96-5p 33 CACNA1E Sponge network 0.433 0.33816 -0.022 0.97264 0.372
44

EMX2OS

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-141-3p;hsa-miR-148a-5p;hsa-miR-148b-5p;hsa-miR-200b-3p;hsa-miR-20a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 12 MAP4K4 Sponge network 1.057 0.31716 0.009 0.99524 0.368
45

EMX2OS

 hsa-let-7a-3p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-186-5p;hsa-miR-200a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-324-5p;hsa-miR-331-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-374b-5p;hsa-miR-375;hsa-miR-454-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-5p 23 TGFB2 Sponge network 1.057 0.31716 0.567 0.30298 0.36
46

HCG11

 hsa-miR-107;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-21-3p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 10 CACNA2D1 Sponge network 0.419 0.63279 0.211 0.75224 0.356
47

CECR7

 hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-1266-5p;hsa-miR-1304-5p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-200c-5p;hsa-miR-20a-5p;hsa-miR-29a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-362-5p;hsa-miR-425-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-592;hsa-miR-7-1-3p;hsa-miR-92a-1-5p;hsa-miR-93-5p;hsa-miR-942-5p 40 CACNA1E Sponge network 0.551 0.56177 -0.022 0.97264 0.351
48

EMX2OS

 hsa-miR-10a-5p;hsa-miR-148b-5p;hsa-miR-17-3p;hsa-miR-18a-3p;hsa-miR-27a-3p;hsa-miR-27b-5p;hsa-miR-29a-5p;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-484;hsa-miR-505-5p;hsa-miR-582-3p;hsa-miR-589-3p;hsa-miR-7-1-3p;hsa-miR-760;hsa-miR-93-3p;hsa-miR-940 18 MAPT Sponge network 1.057 0.31716 0.906 0.06727 0.349
49

EMX2OS

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-128-3p;hsa-miR-130b-3p;hsa-miR-144-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-200b-3p;hsa-miR-27a-3p;hsa-miR-32-3p;hsa-miR-331-3p;hsa-miR-339-5p;hsa-miR-374b-5p;hsa-miR-452-3p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 20 TGFBR1 Sponge network 1.057 0.31716 0.001 0.99924 0.345
50

ZNF883

 hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-182-5p;hsa-miR-26a-1-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29a-5p;hsa-miR-29b-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-582-5p 15 MRAS Sponge network 0.913 0.16772 0.229 0.7586 0.344
51

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-107;hsa-miR-144-3p;hsa-miR-146a-5p;hsa-miR-148a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-21-3p;hsa-miR-215-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-32-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-374a-3p;hsa-miR-374b-5p;hsa-miR-424-5p;hsa-miR-452-5p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p 36 FGF2 Sponge network 1.057 0.31716 0.037 0.94566 0.343
52

EMX2OS

 hsa-let-7g-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-20a-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-25-3p;hsa-miR-26a-2-3p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-335-3p;hsa-miR-421;hsa-miR-505-3p;hsa-miR-550a-3p;hsa-miR-577;hsa-miR-582-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-92a-3p 26 CACNB4 Sponge network 1.057 0.31716 0.442 0.35016 0.342
53

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-362-3p;hsa-miR-374b-5p;hsa-miR-421;hsa-miR-454-3p;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-642a-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 35 PDGFRA Sponge network 1.057 0.31716 -0.146 0.90295 0.34
54

ZNF883

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-16-2-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-582-3p;hsa-miR-590-5p 10 FGF7 Sponge network 0.913 0.16772 0.117 0.8481 0.339
55

HCG11

 hsa-let-7g-5p;hsa-miR-107;hsa-miR-10a-3p;hsa-miR-130b-5p;hsa-miR-186-5p;hsa-miR-26a-1-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-744-3p 11 MEF2C Sponge network 0.419 0.63279 0.174 0.82808 0.334
56

CECR7

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-141-3p;hsa-miR-148a-5p;hsa-miR-148b-5p;hsa-miR-200b-3p;hsa-miR-20a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-7-1-3p 12 MAP4K4 Sponge network 0.551 0.56177 0.009 0.99524 0.322
57

CECR7

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-148a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-24-3p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-32-3p;hsa-miR-331-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-362-3p;hsa-miR-425-5p;hsa-miR-429;hsa-miR-502-5p;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-625-5p 41 TAOK1 Sponge network 0.551 0.56177 -0.005 0.9951 0.32
58

MEG3

 hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-10a-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-200c-5p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-425-5p;hsa-miR-429;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-96-5p 16 MEF2C Sponge network 0.433 0.33816 0.174 0.82808 0.307
59

EMX2OS

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-590-3p 10 PDGFB Sponge network 1.057 0.31716 0.313 0.74314 0.304
60

ZNF883

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-301a-3p 10 MAP3K12 Sponge network 0.913 0.16772 0.29 0.54449 0.303
61

ZNF883

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-33a-3p 10 AKT3 Sponge network 0.913 0.16772 0.457 0.53933 0.3
62

MEG3

 hsa-miR-146a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-577;hsa-miR-590-5p 16 FGF2 Sponge network 0.433 0.33816 0.037 0.94566 0.296
63

ZNF883

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-107;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-576-5p 12 CACNA2D1 Sponge network 0.913 0.16772 0.211 0.75224 0.293
64

MEG3

 hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-186-5p;hsa-miR-200a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-590-5p 12 TGFB2 Sponge network 0.433 0.33816 0.567 0.30298 0.282
65

ZNF883

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-10a-3p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200c-5p;hsa-miR-26a-1-3p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-590-5p 21 MEF2C Sponge network 0.913 0.16772 0.174 0.82808 0.28
66

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-197-3p;hsa-miR-200b-3p;hsa-miR-29a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-627-5p 13 FGF12 Sponge network 0.551 0.56177 -0.073 0.90082 0.278
67

EMX2OS

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-148b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-1976;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-378a-5p;hsa-miR-421;hsa-miR-484;hsa-miR-577;hsa-miR-589-3p;hsa-miR-660-5p;hsa-miR-7-1-3p;hsa-miR-877-5p;hsa-miR-93-3p 25 CACNA1C Sponge network 1.057 0.31716 0.624 0.47829 0.278
68

CECR7

 hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-191-5p;hsa-miR-210-3p;hsa-miR-26b-3p;hsa-miR-29b-1-5p;hsa-miR-30b-5p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 14 BDNF Sponge network 0.551 0.56177 0.503 0.16933 0.274
69

EMX2OS

 hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-192-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-21-3p;hsa-miR-26b-5p;hsa-miR-335-5p;hsa-miR-378a-3p;hsa-miR-532-3p;hsa-miR-592;hsa-miR-760;hsa-miR-93-3p 15 RPS6KA2 Sponge network 1.057 0.31716 0.145 0.89703 0.27
70

EMX2OS

 hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-148a-5p;hsa-miR-151a-5p;hsa-miR-15b-3p;hsa-miR-17-3p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-301a-3p;hsa-miR-30d-3p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-421;hsa-miR-452-3p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-760;hsa-miR-940 25 NTRK2 Sponge network 1.057 0.31716 0.714 0.34423 0.268
71

CECR7

 hsa-let-7a-3p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-186-5p;hsa-miR-200a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-331-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-362-5p;hsa-miR-375;hsa-miR-429;hsa-miR-454-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p 23 TGFB2 Sponge network 0.551 0.56177 0.567 0.30298 0.267
72

MEG3

 hsa-miR-141-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-29b-1-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-590-5p;hsa-miR-7-1-3p 14 PRKCB Sponge network 0.433 0.33816 -0.289 0.6299 0.266
73

EMX2OS

 hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-191-5p;hsa-miR-210-3p;hsa-miR-26b-3p;hsa-miR-29b-1-5p;hsa-miR-32-3p;hsa-miR-339-5p;hsa-miR-33a-3p;hsa-miR-452-3p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 16 BDNF Sponge network 1.057 0.31716 0.503 0.16933 0.259
74

CECR7

 hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-192-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-335-5p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-532-3p;hsa-miR-592;hsa-miR-760 14 RPS6KA2 Sponge network 0.551 0.56177 0.145 0.89703 0.258
75

EMX2OS

 hsa-miR-107;hsa-miR-141-3p;hsa-miR-185-3p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-197-3p;hsa-miR-200a-3p;hsa-miR-335-3p;hsa-miR-362-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-940 13 CACNA1B Sponge network 1.057 0.31716 0.763 0.45307 0.254
76

EMX2OS

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-148a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29a-5p;hsa-miR-32-3p;hsa-miR-324-5p;hsa-miR-331-5p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-362-3p;hsa-miR-374b-5p;hsa-miR-424-5p;hsa-miR-425-5p;hsa-miR-502-5p;hsa-miR-505-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-625-5p 43 TAOK1 Sponge network 1.057 0.31716 -0.005 0.9951 0.254

Quest ID: c63aa497e0fc4c00549de78a2477e6f2